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ABSTRACT

SPEECH OUTCOMES AND HEARING PRESERVATION IN ADULTS WITH HYBRID
COCHLEAR IMPLANTS: A SYSTEMATIC REVIEW
by
VICTORIA DILLON

Advisor: Dr. Barbara Weinstein, Ph.D.
Objective: The goal of this review is to systematically review literature in order to investigate
the speech recognition and subjective performance outcomes, as well as determine the degree of
hearing preservation, in adult hybrid cochlear implant patients through the utilization of electric
acoustic stimulation (EAS).
Methods: A comprehensive search, utilizing various peer-reviewed databases, was conducted
via the City University of New York’s (CUNY) Graduate Center Library to identify the relevant
studies published. Inclusion criteria was studies that involved adult hybrid cochlear implant users
which reported speech outcomes and hearing preservation, with performance outcomes obtained
at least 12 months’ post-implantation. Studies published before 2013 were not included in this
study in order to represent current literature in the field.
Results: Ten studies met the inclusion and exclusion criteria for this systematic review. These
studies included various materials to assess both speech recognition performance and subjective
outcomes. All studies also reported on the degree of hearing preservation maintained postimplantation. Results revealed that, overall, subjects experienced a significant improvement in
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speech recognition scores in quiet and in noise. The benefit of utilizing acoustic stimulation, in
addition to traditional electric stimulation through the cochlear implant, was also of note.
Subjects had an overall positive improvement in subjective outcomes following hybrid cochlear
implantation. Varying degrees of hearing were preserved after surgery, with the overwhelming
majority maintaining “functional” hearing for EAS.
Discussion: Significant improvements were found pre-to post-operatively in speech recognition
outcomes and in subjective report. From this it can be concluded that these individuals, who
would not have been traditional cochlear implant candidates, experienced significant positive
changes from hybrid cochlear implantation. Additionally, high degrees of hearing preservation
were maintained following surgery, further supporting the notion that cochlear implant
candidacy criteria should be expanded to include this population. Future research may focus on
the discontinued use of EAS, audiologist referral of this population, and the quantifying of
benefit of the acoustic component in the hybrid cochlear implant system.
Conclusion: This systematic review assessed the literature regarding speech outcomes,
subjective outcomes, and hearing preservation of hybrid cochlear implant users. The positive
findings concluded in this review many serve as justification and evidentiary support of the
expansion of cochlear implant criteria to include this underserved population.
Key words: “hybrid cochlear implant”, “electric acoustic stimulation”, “speech outcomes”,
“speech recognition”, “subjective outcomes”, “quality of life outcomes”, “hearing preservation”,
“hearing preservation surgery”.
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Introduction
Hybrid cochlear implantation, or Electric Acoustic Stimulation (EAS), has become an
increasingly popular topic with the goal of expanding cochlear implantation candidacy and
criteria. The notion of a hybrid cochlear implant came to fruition in 1995 when a senior author at
Cochlear Americas was tasked with the concept of creating an implant electrode that could
preserve low frequency hearing in the cochlea (Gantz et al., 2016). Traditionally, cochlear
implants in post-lingually deafened adults have been recommended to those individuals for
which traditional amplification is inadequate for hearing restoration. When the damage to the
hair cells of the cochlea is so extensive they cannot be adequately stimulated acoustically, a
cochlear implant will provide direct electric stimulation to the auditory nerve through implanted
electrodes. This new electrical signal, rather than acoustic signal, is sent to the brain and
interpreted as sound. The introduction of multichannel implants have worked to improve this
encoding of speech and environmental signals into meaningful sound (Speech Processing in the
Auditory System, 2004). Until recent years, the idea of preserving residual hearing in the cochlea
was not a possibility, due to the acoustic trauma and damage the cochlea may experience during
implantation surgery. However, this idea has become feasible with improved surgical techniques,
drug delivery systems, and changes to electrode array lengths and dimensions (Gifford et al.,
2013). Most frequently, if a post-lingually deafened individual has functional hearing, it’s likely
in the apical region of the cochlea, which tonotopically encodes low frequency acoustic signals.
This is likely because the high frequency base of the cochlea tends to sustain the greatest damage
first. It has been said that the hearing in this region is critical in understanding speech in noise,
sound localization, and music appreciation. Traditional cochlear implantation speech processing
is usually not able to preserve these finer spectral cues (Gantz et al., 2016). Hearing preservation
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has now been made feasible and demonstrated with shorter electrodes with shorter insertion
depth, therefore avoiding contact with apical hair cells, and with long electrodes with deep
insertion depths, through improved surgical techniques which minimize damage to the inner ear.
As a result of this, electrical stimulation in the basal end of the cochlea can be combined with
traditional acoustic amplification to the preserved low frequencies in the apical end (Woodson et
al., 2009).
Currently, according to the Food and Drug Administration (FDA) 2000, traditional
cochlear implantation candidacy for adults 18 years and older specifies the individual meet the
following criteria: Moderate to severe low frequency hearing loss and profound high frequency
hearing loss; £50% aided sentence recognition in the ear to be implanted and £60% in the
contralateral ear or best aided condition. Candidacy criteria is also influenced by implant
manufacturer and insurance payer (Gifford, 2013) Off-label usage of a cochlear implant is the
current practice which allows deviations from the limiting criteria candidacy previously stated.
While implant manufacturers are not allowed to promote such usage of their devices, clinicians
are granted the professional courtesy to make such clinical determinations (Gifford, 2013). The
FDA has released an informational sheet specifically to help clinicians navigate this
determination, entitled, “Off-Label and Investigational Use of Marketed Drugs, Biologics, and
Medical Devices” (FDA, 2018). The ability to make this determination comes with the
responsibility to adhere to several conditions, including; “be well informed about the product”,
“base its use on firm scientific rationale and on sound medical evidence”, and “maintain records
of the product’s use and effects” (FDA, 2018)(Gifford, 2013). The ability to stretch these
candidacy criteria will be most beneficial for those patients with atypical hearing losses, such as
single sided deafness, patients with poor word recognition, and those with aidable low frequency
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hearing who could benefit from electrical stimulation of the middle to high frequencies. This
pattern of progressive down-sloping high frequency hearing loss is seen in individuals with
familial hearing loss, ototoxicity, presbycusis, or noise-induced hearing loss (Woodson et al.,
2009). These “atypical” candidates are not considered in the current guidelines for cochlear
implantation, however, this practice of off-label usage of medical devices has become an
“acceptable and necessary corollary of the FDA’s mission” in order to provide adequate
standards of care according to the U.S. supreme court (Gifford, 2013). However, there are nonaudiological considerations to account for when making such recommendations. These
considerations include whether the patient is highly motivated, whether they have realistic
expectations in outcomes, whether they are willing to participate in extensive follow-up, and
whether there are other medical concerns or contraindications to surgery. Subject to these
factors, surgeon support, and insurance approval, qualified patients now have a way to get the
amplification and technology needed to adequately treat their hearing loss beyond what is
possible with traditional amplification.
The added benefits of electric and acoustic stimulation in cochlear implantation have
been well documented. Much of these advantages are due to the current limitations of purely
electric stimulation as they relate to low frequency acoustic cues. These limitations take form in
the realm of music appreciation, processing in noise, and localization in space. The availability
of low frequency pitch information in hybrid CI users has been shown to aid music perception
abilities in terms of melody recognition and certain instrument recognition tasks. This is likely
due to the fact that the low frequency pitch information, which is critical for these tasks, is not
preserved in signal processing through conventional cochlear implantation, inhibiting such
abilities (Woodson et al., 2009). Much of pitch perception is affected by the tonotopic mismatch
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between the standard tonotopic organization and the cochlear place of electric stimulation on the
processor map. This may lead to the detriment of music appreciation, however, it should be
noted that studies have shown patients can overcome this change in pitch perception with
adaptation to the device over time (Woodson et al., 2009). Other studies have revealed similar
findings related to hybrid cochlear implant users and their music and pitch perception abilities.
Hybrid users have also reported better sound quality, improved abilities in pitch ranking tasks,
and improved recognition of real-world songs (Looi et al., 2012). The incorporation of low
frequency information through acoustic stimulation is thought to enable some of the low
frequency fine structure cues to be preserved in the signal. This increases the potential that the
listener can extract fundamental frequency information from the signal (Kong et al., 2005). It’s
been hypothesized that the temporal fine structure information, or the fine changes in the
amplitude and frequency of sound over time, may be mostly lost in cochlear implant speech
processing strategies. Researchers have proposed that listeners “might use the correlation
between the salient pitch in low-frequency acoustic hearing and the weak pitch in the envelope to
enhance segregation between the signal and noise” (Kong et al., 2005). Based on these studies,
researchers have concluded that fine structure low frequency information appears to be more
important for music perception and appreciation. Currently, the limitations of speech processing
strategies in traditional cochlear implants and the large tonotopic mismatch in the cochlea
affecting low frequency information seems to be evidence supporting the use of electric acoustic
stimulation, whenever possible, for improved music perception (Looi et al., 2012). Similar
conclusions have been suggested for the use of preserved low frequency hearing in
understanding speech in noise. It has been hypothesized that preservation of interaural timing
difference (ITD) cues could be responsible for improved signal to noise ratios in hybrid users
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(Gifford et al., 2013). Interaural timing differences refers to the acoustic cue that comes from
difference in arrival time of the signal to each ear and are most useful for low frequency sounds.
These timing differences are thought to be somewhat lost with cochlear implantation without
hearing preservation. A number of studies have documented the improved localization abilities
and improved speech understanding in noise with access to low frequency acoustic hearing. It
appears that ITD cues are part of the underlying mechanism for these abilities in this population
of hybrid CI users (Gifford et al., 2014). Another explanation for this improved ability may be
the use of Interaural Level Differences (ILD), the acoustic cue that comes from difference in
sound level or loudness reaching each ear. There may also be additional support for difficult
listening environments through a more minor use of the head and torso shadow effect. Though
traditionally thought to be of the greatest use for high frequency information, more recently,
research related to head related transfer functions suggest that low frequency sounds may be able
to take advantage of this cue as well (Gifford et al., 2013). Users of EAS have the added benefit
of taking advantage of both inter-aural timing differences and inter-aural level differences for
improved localization abilities and separation of the target signal from noise (Gifford et al.,
2013).
The hybrid cochlear implant has only become a possibility in recent years due to
improved surgical techniques and an emphasis on hearing preservation within the cochlea. In the
first attempts to employ electric and acoustic hearing systems, CI manufacturers and surgeons
worked with a “short” electrode array, or an electrode array that was intended not to affect or
cover the apical end of the cochlea with low frequency hearing. With more shallow insertion into
the cochlea and “soft surgery” techniques, surgeons attempted to preserve the delicate structures
within the apical end of the cochlea (Woodson et al., 2009). Over time, this practice of hearing
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preservation during cochlear implant surgery has been practiced and refined. Short electrode
arrays are still used today at the discretion of the surgeon. More recently surgeons have moved
towards the use of full length electrodes with surgical techniques that hope to create less acoustic
trauma upon insertion, therefore leaving the structures intact and usable. This approach allows
for the electrical stimulation of this region of the cochlea in the future, should the hearing decline
and become unaidable acoustically. Some of these “softer” techniques include minimizing the
cochlear exposure to blood and bone dust, performing a more minimally invasive cochleostomy,
and careful insertion of the electrode array to avoid damage to the basilar membrane (Woodson
et al., 2009). Further research into surgical placement of electrodes for better hearing
preservation has led to the development of different electrode arrays for lateral wall and
perimodiolar placement. Lateral wall placement refers to the surgical technique of inserting the
electrode array along the outer or lateral wall of the cochlea, farthest from the modiolus. A
perimodiolar electrode is designed to be inserted close to the medial margin of scala tympani
closest to the modiolus (Group Product Manager, Surgical & Implants, Cochlear Limited, New
South Wales, Australia & Risi, 2019). Researchers believe that lateral wall electrodes may be
better for hearing preservation as they were designed to be flexible and cause minimal damage to
the most important delicate structures upon insertion. With surgical techniques and electrode
arrays only improving, hearing preservation has become possible. With greater hearing
preservation comes greater ability to utilize the low frequency hearing for hybrid cochlear
implant users.
The goal of this systematic review is to review the literature in order to determine the
speech recognition and subjective performance outcomes, as well as hearing preservation
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outcomes, of adult hybrid cochlear implant patients or those that use EAS. The following
research questions will be addressed:
1. Does electric acoustic stimulation (EAS) through the use of hybrid cochlear implants improve
speech recognition outcomes in adults? If so, to what degree?
2. What were the subjective improvements experienced by the EAS subjects on qualitative
outcome measures?
3. What proportion of hybrid cochlear implantees maintained low frequency residual hearing
following cochlear implant surgery? If so, to what degree was low frequency hearing preserved?
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Methods
A comprehensive review was performed investigating speech outcomes and hearing
preservation of adults with hybrid cochlear implants or electric acoustic stimulation systems. A
literature search was conducted via the Mina Rees Library databases of the Graduate Center of
The City University of New York (CUNY) to identify relevant studies published. Databases
included PubMed, Medline Complete, Google Scholar, ProQuest, EBSCO, PsycINFO, and Web
of Science. Various combinations of the following key terms were used to locate the pertinent
literature: “cochlear implant”, “hybrid cochlear implant”, “hybrid”, “adult”, “electric acoustic
stimulation”, “EAS”, “speech outcomes”, “speech in noise”, “speech recognition”, “hearing
preservation”, “hearing preservation surgery”, “severe to profound hearing loss”, “quality of life
outcomes”, “subjective outcomes”, “low frequency pure tone thresholds”, “candidacy”.
Inclusion and exclusion criteria in this review were put in place to capture the relevant
subject pool, while allowing for a substantial range of patients. Inclusion criteria included the
following: Adult subjects 18 years and older, users of one of the three major cochlear implant
manufacturers (Advanced Bionics, Cochlear Americas, Med-El), auditory performance/ speech
outcomes obtained at least one-year post-cochlear implantation, adult-onset hearing loss, and
reported hearing preservation outcomes. Exclusion criteria included the following: Studies
published prior to 2013 to represent current literature in this field, pediatric subjects or patients
17 years of age or younger, unspecified follow-up period, unspecified device types, excessively
small sample size (n < 6 subjects). Additional search-based exclusion criteria included nonEnglish articles (not translated), articles that were not available as full-length, unpublished
articles, or non-peer reviewed articles. It should be noted that in some studies, data was taken
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from multi-center trials and therefore there is the potential for subject cross-over amongst the
studies included in this review.
The inclusion and exclusion of the published studies discussed in this systematic review
was guided by and outlined by the PRISMA (Preferred Reported Items for Systematic Reviews
and Meta-Analyses) checklist and flow diagram (The PRISMA group, 2009). Application of
these criteria resulted in 10 articles being chosen for this review.

9

Results
Figure 1 shows a PRISMA flowchart of the literature search and retrieval process for this
systematic review. The initial database search yielded a total of 171 studies. Perusal of abstracts
of retrieved articles as well as elimination of articles outside of specified range of publication
year, resulted in the elimination of 136 articles.

Figure 1. PRISMA flowchart of the literature search, retrieval process and selection of studies
for this systematic review (The PRISMA group, 2009).
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This culminated in 35 full-text articles which were assessed for eligibility in this review. After a
thorough examination of the articles, 25 were eliminated for the following reasons: article did
not include speech outcomes/measures, article did not specify a follow-up period and/or followup time was <12 months, articles included pediatric or child subjects, article had a sample size
<6 subjects, article was a review article or was not peer-reviewed. Application of this criteria
resulted in 10 eligible articles to be included in this review.

Study Characteristics
Table 1 displays a number of characteristics regarding the studies included in this review.
It includes the study type or design, the speech measures and materials used, the subjective
measures and materials used, the timeline of follow-up testing, the condition(s) in which subjects
were tested, and the studies defined degrees of hearing preservation.
Inspection of Table 1 reveals that 80% (8 of 10) of studies were prospective in nature,
while two studies, Roland, J. T. et al, 2018 and Santa Maria et al., 2013, were retrospective. Of
the 10 studies included, 5 studies were from, or were a part of, a multicenter trial or study inside
and outside the United States. The speech materials used to determine speech recognition
outcomes varied, with some common measures throughout. The most common measure used to
assess outcomes pre- and post-operatively was consonant-nucleus-consonant (CNC) words. 50%
(5 of 10) studies included CNC words as one of their speech measures. Several of the studies
also included some kind of speech in noise measure. These other materials included CUNY
sentences in noise, Bamford-Kowal-Bench Speech-in-Noise Test (BKB-SIN), AzBio sentences
in noise, and a number of other unspecified speech in noise tests in the language of the country
of origin. As a secondary measure, subjective tests and questionnaires, based on patient report,
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were also extracted from the data. The most common subjective outcome measure used was the
Speech and Spatial Qualities scale (SSQ). 4 of the 7 studies which identified a subjective
measure used the SSQ to assess subject’s subjective improvements following cochlear
implantation in a number of contexts. Other subjective measures included the Abbreviated
Profile for Hearing Aid Benefit (APHAB), Glasgow Benefit Inventory (GBI), Glasgow Hearing
Aid Benefit (GHABP), and a Likert scale to measure quality of experience. The timeline of
subject’s follow-up was also reported to ensure there was a minimum of 12 months of cochlear
implant usage when final measurements were recorded. All studies did various forms of testing
pre-operatively. Post-operatively, the follow-up timeline ranged from at the initial activation, or
approximately 1-month post-operatively, to over 5 years post-operatively. The most common
follow-up timeline was 1 month, 3 months, 6 months, and 12 months post-operatively. 4 studies
(Carvalho et al., 2013; Härkönen et al., 2017; Roland et al., 2018; Santa Maria et al., 2013)
recorded measurement points well beyond 12 months post-operatively. Due to the great variety
in testing conditions, as well as the differences of in-study comparisons, the amplification
conditions in which subjects were tested were also reported. 6 of the 10 studies required subjects
to be tested in a number of different amplification configurations. The most common
comparisons were combinations of the hybrid cochlear implant, the hybrid cochlear implant with
a contralateral hearing aid, the cochlear implant with electric stimulation only (no acoustic
component), or bilateral hearing aids (acoustic hearing only). The allowed researchers to make
in-study comparisons about the use of EAS and its potential benefits. The final study
characteristic reported was the studies defined degrees of hearing preservation. Each study
defined degrees of hearing preservations differently to reflect what they considered “functional”
verses “non-functional” hearing preservation. All studies also reported how many subjects
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experienced a total loss of hearing following surgery. Some studies chose to report when the
subject maintained some degree of preserved hearing, but that preserved hearing was nonfunctional for the purpose of electric acoustic stimulation through the hybrid cochlear implant.
Other studies chose to report this as hearing that was beyond the limits of the audiometer used to
obtain thresholds. Degrees of hearing preservation were most often based on changes in the low
frequency pure tone average. Degrees of preserved hearing in the high frequencies were not
reported due to their inconsequentiality to acoustic stimulation through the hybrid cochlear
implant.
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Table 1. Study Characteristics
Study

Study Type

Speech Outcomes
Materials/ Measures

Adunka, O. F., et al.
(2013). Hearing
preservation and speech
perception outcomes
with electric-acoustic
stimulation after 12
months of listening
experience: Hearing
Preservation and Speech
Perception Outcomes
with EAS. (Adunka et
al., 2013)
Carvalho, G. M. et al.
(2013). Hearing
Preservation after
Cochlear Implantation:
UNICAMP Outcomes.
(Carvalho et al., 2013)

Single Center
data from a
prospective,
multicenter
clinical trial

CNC words in quiet;
CUNY sentences in noise
(+10dB/+5dB SNR)

Prospective
Cohort study

Speech perception test
[based on test developed
by Bevilacqua et al. from
several English language
tests]

Subjective
Materials/
Measures
---

Timeline of
Follow-up
Testing
Pre-operatively;
3 months’ postop;
6 months, postop;
12 months’
post-op

Quality of
experience
rating using
Likert scale

Pre-operatively;
at activation;
195-218 postactivation (2nd
post-op);
174-251 days
after 2nd post-op

Subject Testing
Condition
(1) Hearing aid alone
(2) CI alone
(3) EAS

Best-aided condition
(1) EAS if possible
(2) CI-Only

Degrees of Hearing
Preservation
Specified
No hearing
preservation;
Partial hearing
preservation [mean
threshold changes
reported by
frequency]

Total hearing
preservation:
postoperative unaided
hearing loss of 0–
10 dB;
Partial hearing
preservation:
postoperative unaided
hearing loss of >10 dB
but ≤80 dB hearing or
better in at least one
frequency between
250 and 1000 Hz;
Hearing preservation
failure: unaided
postoperative
thresholds are >80 dB
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Gantz, B. J., et al.
(2016). Multicenter
clinical trial of the
Nucleus Hybrid S8
cochlear implant: Final
outcomes: S8 Hybrid
Cochlear Implants.
(Gantz et al., 2016)

Prospective,
multicenter,
longitudinal,
single-subject
design.

CNC words in quiet; BKB
SIN

Abbreviated
Profile for
Hearing Aid
Benefit
(APHAB)

Pre-operatively;
3 months’ postop;
6 months’ postop;
12 months’
post-op

Härkönen, K., et al.
(2017). Hybrid cochlear
implantation: quality of
life, quality of hearing,
and working
performance compared
to patients with
conventional unilateral
or bilateral cochlear
implantation.(Härkönen
et al., 2017)
Lenarz, T., et al. (2013).
European multi-centre
study of the Nucleus
Hybrid L24 cochlear
implant. (Lenarz et al.,
2013)

Prospective
cohort study

Disyllabic, phonetically
balanced Finnish words in
noise (validated for
adults)

Glasgow
Benefit
Inventory
(GBI);
Speech,
Spatial and
Qualities of
Hearing Scale
(SSQ)

Pre-operatively;
1-month postop;
average of
3.6yrs post-op
(range 1.7-5.1
yrs post-op)

Prospective
study, with
sequential
enrollment
and withinsubject
comparisons.

Speech recognition in
quiet and noise using
disyllabic and
monosyllabic words in
local languages (France
[Fournier lists, 20 items],
Italy [GN Resound 2000,
20 items] and Spain
[University of Navarra,
Adult, 25 items]. Lists of
monosyllabic words were
used in Belgium [NVA,
40 items], Germany

Speech and
spatial
qualities scale
(SSQ);
Healthy
Utility Index
mk3 (HUI)

Pre-operatively;
1-month postop;
3 months’ postop;
6 months’ postop;
12 months’
post-op

(1) Acoustic hearing
implant ear
(2) Acoustic hearing
bilaterally
(3) Hybrid CI +
contra HA (combined
mode)
(4) Hybrid CI only
(hybrid mode)
(5) CI only (Electric
only)
(6) CI (electric only)
+ contra HA
(bimodal)
(7) Ipsilateral acoustic
only
Hybrid CI with
contralateral hearing
aid (x6 subjects);
Bilateral hybrid CIs
(x2 subjects)

Functional hearing
preservation (<85-90
dBHL PTA of 125 to
1kHz [LFPTA]);
Non-functional
hearing preservation
(>90 dB LFPTA);
Total loss of hearing
(>130dBHL)

(1) Hybrid CI alone
(2) Best aided
condition using
hybrid CI

Completely conserved
(defined as: less than
or equal to 10 dB
threshold increase);
Partially or
completely conserved
(defined as: less than
or equal to 30 dB
threshold increase)
[at one month and
one-year postimplantation]

Mean LF hearing
threshold decline 125500Hz in the
implanted and nonimplanted ear;
Total loss of residual
low-frequency hearing
after implantation.
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[Freiburg monosyllables,
20 items], the Netherlands
[NVA, 20 items] and
United Kingdom [AB
words, 20 items])
CNC words; AzBio
sentences in noise

Roland, J. T., et al.
(2016). United States
multicenter clinical trial
of the cochlear nucleus
hybrid implant system:
Nucleus Hybrid Implant
System Clinical Trial.
(Roland et al., 2016)

Prospective,
single-arm
repeated
measures,
single-subject
design

Speech,
Spatial and
Qualities of
Hearing Scale
(SSQ)

Roland, J. T., et al.
(2018). Long-term
outcomes of cochlear
implantation in patients
with high-frequency
hearing loss: Long-Term
Electric-Acoustic
Hearing Outcomes.
(Roland et al., 2018)

Retrospective
study of
compiled data
from related
clinical
studies

CNC in quiet

Speech,
Spatial and
Qualities of
Hearing Scale
(SSQ)

Santa Maria, P. L., et al.
(2013). Hearing
Preservation Surgery
for Cochlear
Implantation—Hearing
and Quality of Life
After 2 Years.
(Santa Maria et al.,
2013)

Retrospective
cohort study

BKB sentences in quiet;
CNC words in quiet; BKB
SIN

Abbreviated
Profile of
Hearing Aid
Benefit
(APHAB);
Glasgow
Hearing Aid
Benefit

Pre-operatively;
1-month postop;
3 months’ postop;
6 months’ postop;
12 months’
post-op
Pre-operatively;
1 yr post-op;
3 yrs post-op;
5 yrs post-op

(1) Hybrid system
with contralateral ear
plugged to mitigate
contribution
(2) Hybrid system in
combination
with acoustic hearing
in the opposite, unimplanted ear.
(1) Best unilateral
condition [hybrid if
possible or total
electric]
(2) Best bilateral
condition [hybrid+
HA in contra ear or
bimodal]

Profound hearing loss
(greater than
90dBHL);
Functional acoustic
hearing (less than or
equal to 90dBHL)

Pre-operatively;
<3 months’
post-op;
6-12 months’
post-op;
12-24 months’
post-op;
>2 yrs post-op

EAS condition if
hearing was
preserved;
CI only condition if
not preserved

Complete hearing
preservation (0-25%);
Partial hearing
preservation (2560%);
Minimal hearing
preservation (>60%);
Complete loss of

Functional residual
hearing (defined as: 5
frequency LF PTA
[125-1kHz] greater
than or equal to 90
dBHL);
Measurable hearing
(defined as: any
measurable threshold
within that frequency
range);
Total Loss (defined
as: no measurable
thresholds at the limits
of the audiometric
equipment)
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Skarzynski, H., et al.
(2014). Cochlear
Implantation with the
Nucleus Slim Straight
Electrode in Subjects
with Residual LowFrequency Hearing.
(Skarzynski et al., 2014)
Usami, S.-I., et al.
(2014). Hearing
preservation and clinical
outcome of 32
consecutive electric
acoustic stimulation
(EAS) surgeries.
(Usami et al., 2014)

Prospective
study, with
sequential
enrollment
and withinsubject
repeated
measures.
Prospective
study

Polish monosyllabic
words in quiet; Polish
monosyllabic words in
noise (+10dB SNR)

Speech
discrimination (using the
67S Japanese
monosyllable
test); Monosyllable
speech perception; word
perception; sentence
perception (using the
Japanese CI2004
monosyllable, word and
sentence test);

(GHABP
Scales)
--

--

Pre-operatively;
1-month postop;
4 months’ postop;
7 months’ postop;
1-year post-op
Pre-operatively;
1-month postop;
3 months’ postop;
6 months’ postop;
12 months’
post-op

(1) Pre-operatively
tested aided and
unaided
(2) Post-operatively
tested with hybrid
processor and with or
without HA in
contralateral ear
(1) Hearing
aid alone
(2) CI alone
(3) Combined EAS

hearing (no
measurable hearing)
Hearing preservation
at 500Hz
(1) preserved within
10dB of pre-op values
(2) preserved within
30dB of pre-op values
Average change in
threshold 125-1000Hz
from pre-op to 1month post-op

BKB-SIN: Bamford-Kowal-Bench Speech-in-Noise test; BKB sentences: Bamford-Kowal-Bench sentences; CI: Cochlear implant; contra: contralateral; CNC
words: Consonant- Nucleus- Consonant words; CUNY: City University of New York; HA: Hearing Aid
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Subject Characteristics
Table 2 displays the demographic and historical characteristics of the subjects included in
all 10 studies. Total overall sample size across the 10 studies was 326 subjects with an average
sample size of 32.6 subjects. Studies ranged in sample size from 6 to 68 participants. The
following subject characteristics were extracted when possible: Age at implantation and subject’s
age range, gender split, duration of hearing loss (as defined by study), etiology of subject’s
hearing loss, cochlear implant manufacturer and type. The average age of implantation across all
studies was 52.92 years and the age range was 15 to 86.2 years. It should be noted that one
subject from Skarzynski et al., 2014 fell outside the specified criteria of 18 years and older. As
no individual information could be extracted from the study regarding this subject, he or she was
included in this review. Given the proximity to the inclusion age, it is unlikely the inclusion of
this subject affected the findings. Excluding this subject, the youngest participant was 19.6 years
old. Average gender split revealed 204 female subjects and 122 male subjects, making the
majority of participants female. Duration of subject’s hearing loss was reported in 9 of 10
studies. Determining adult subject’s exact duration of hearing loss is difficult as at the age of
diagnosis, the hearing loss is often already longstanding, hence the definition of “duration of
hearing loss” varied dramatically. The average duration was 23.6 years with shortest average
duration being 11.3 years in Carvalho et al., 2013 and longest average duration being 37 years in
Adunka et al., 2013. Etiology of hearing loss was reported individually for all subjects with the
exception of 1 study (Usami et al., 2014), however, by far the most reported etiology was
“unknown”. 6 of the 10 studies reported “unknown” as the most common etiology. Similarly, in
3 of 10 studies, more than 50% of the subject’s etiology was “idiopathic”. It can be concluded
that for the majority of the subjects included in this study, the onset of hearing loss did not have a
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specific etiology or cause. Other etiologies included hereditary/familial/genetic, noise induced
hearing loss, presbycusis, ototoxicity/chemotherapy, otosclerosis, autoimmune disease, fever,
measles, and inner ear disease. Exact percentages of subjects with these etiologies can be found
in Table 2. Implants used in this study came from either Cochlear Americas (6 studies) or MedEl (4 studies). Advanced Bionics was the only cochlear implant manufacturer currently in
circulation that was not included in the given studies (note: at the time of data collection for the
studies in this review, Oticon Medical cochlear implants were not being distributed in the United
States). Of the 6 studies utilizing Cochlear America’s implant systems, 5 used the Cochlear
Nucleus L24 electrode array. The 6th study, Skarzynski et al., 2014, utilizes the Cochlear
Nucleus Slim Straight electrode array (Nucleus CI422). Gantz et al., 2016 also included the
Cochlear Nucleus S8 electrode array in specific subjects. The Med-El FLEX24, also called the
FLEXEAS, was used in all 4 studies which utilized Med-El devices. Other Med-El electrode
arrays used were the PulsarCi, SonataTi, FLEXSOFT, and Combi40+.

19

Table 2: Subject Characteristics
Study

Sample Size

Adunka, O. F., et al. (2013).
Hearing preservation and speech
perception outcomes with electricacoustic stimulation after 12
months of listening experience:
Hearing Preservation and Speech
Perception Outcomes with EAS.
(Adunka et al., 2013)
Carvalho, G. M. et al. (2013).
Hearing Preservation after
Cochlear Implantation:
UNICAMP Outcomes.
(Carvalho et al., 2013)
Gantz, B. J., et al. (2016).
Multicenter clinical trial of the
Nucleus Hybrid S8 cochlear
implant: Final outcomes: S8
Hybrid Cochlear Implants.
(Gantz et al., 2016)
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Härkönen, K., et al. (2017).
Hybrid cochlear implantation:
quality of life, quality of hearing,
and working performance
compared to patients with
conventional unilateral or
bilateral cochlear implantation.
(Härkönen et al., 2017)
Lenarz, T., et al. (2013). European
multi-centre study of the Nucleus
Hybrid L24 cochlear implant.
(Lenarz et al., 2013)

Average Age at
Implantation/
Age Range
55 yrs; 20.2-76.6
yrs

Gender Split

Duration of
Hearing Loss

Etiology of
Hearing Loss

Implant Type

38.9%
female;
61.1% male

37.0 ± 17.6 yrs
[defined as first
hearing aid
fitting]

Idiopathic (50%);
noise induced
hearing loss
(22.2%);
hereditary (22.2%);
unknown (5.5%)

Med-El DUET EAS
speech processor;
PulsarCi, SonataTi,
L24 (EAS)
electrode array

6

47 yrs; 29-63 yrs

17% female;
83% male

11.3 yrs (range
of 5 to 20 yrs)

Idiopathic (x6;
100%)

Med-El Flex24 (EAS)
electrode

68

58.8 yrs; 19.682.3 yrs

55.2%
female;
44.8% male

26 ± 13.4 yrs

Unknown (47.1%);
hereditary (25.3%);
noise exposure
(17.2);
inner ear disease
(2.3%);
measles (2.3%);
other (1.1%)

Cochlear Nucleus
Hybrid™ S8;
Nucleus Flex24
(EAS), Nucleus
Freedom Processor

8

49 yrs; 25-70 yrs

62.5%
female;
37.5% male

--

Unknown (x8)

Cochlear Nucleus
Hybrid L24 (EAS)

66

53.46 yrs; 21-81
yrs

79% female;
21% male

13.4 ± 12.2 yrs
[defined as
duration of
severe/profound
high frequency
HL]

Unknown (54%);
familial (19%);
ototoxicity (6%);
otosclerosis (3%);
other (18%)

Cochlear Nucleus
Hybrid L24 (EAS)
and Freedom SP
processor
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Roland, J. T., et al. (2016). United
States multicenter clinical trial of
the cochlear nucleus hybrid
implant system: Nucleus Hybrid
Implant System Clinical Trial
(Roland et al., 2016)
Roland, J. T., et al. (2018). Longterm outcomes of cochlear
implantation in patients with
high-frequency hearing loss:
Long-Term Electric-Acoustic
Hearing Outcomes.
(Roland et al., 2018)

50

61.1 yrs; 23 to
86.2 yrs

50% female;
50% male

32

62.3 yrs; 23-86.2
yrs

53% female;
47% male

Santa Maria, P. L., et al. (2013).
Hearing Preservation Surgery for
Cochlear Implantation—Hearing
and Quality of Life After 2 Years
(Santa Maria et al., 2013)
Skarzynski, H., et al. (2014).
Cochlear Implantation with the
Nucleus Slim Straight Electrode
in Subjects with Residual LowFrequency Hearing
(Skarzynski et al., 2014)
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51 yrs; 32-72 yrs

57% female;
43% male

73% female;
27% male

25.1 ± 12.8 yrs

77% female;
23% male
91% female;
9% male
66.7%
female;
33.3% male

14.4 ± 8.6 yrs

Usami, S.-I., et al. (2014). Hearing
preservation and clinical outcome
of 32 consecutive electric acoustic
stimulation (EAS) surgeries
(Usami et al., 2014)

Group
A

11

Group
B
Group
C
30

13

45.5 yrs;
15-84 yrs [all
subjects]*
45.2 yrs

11

41.4 yrs
47.5 yrs; 21-71
yrs

28.1 ± 14.9 yrs
[overall hearing
loss];
13.1 ± 7.2 yrs
[high frequency
hearing loss]
26.5 ± 12.1 yrs
[overall hearing
loss];
13.6 ± 7.2 yrs
[severe/
profound high
frequency
SNHL’
25 yrs (range of
5- 62 yrs)

Unknown (50%);
noise exposure
(22%);
familial (20%);
other (8%)

Cochlear Nucleus
Hybrid L24 (EAS)
Implant and processor

Unknown (47%);
noise exposure
(28%);
familial (19%);
autoimmune (3%);
fever (3%)

Cochlear Nucleus
Hybrid L24 (EAS)
Implant and processor

Idiopathic (57%);
hereditary (21%);
genetic (7%);
presbycusis (7%);
chemotherapy (7%)
Unknown (69%);
familial (11%);
noise induced
(6%);
other (14%)

Med-EL Flex 24
(EAS) electrode &
Duet 2 processor

Genetic
heterogeneity
involved for all
subjects; no
individual
etiologies reported.

Med-El PULSAR
with 24 mm FLEX 24
(EAS) device (x27);
FLEXSOFT electrode
(x2);
Combi40+ with
standard electrode
(x1)

Cochlear Nucleus
Slim Straight array
(Nucleus CI422) &
Nucleus Freedom
sound processor

21.1 ± 10.1 yrs
25 yrs (range of
3-52 yrs)

*Denotes subject falls outside of specified criteria; subject could not be removed from data due to limited information from study
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Speech Recognition Outcomes
Table 3 displays the speech recognition outcomes reported for subjects in the included
studies. Primary speech outcome measures and materials are listed again for reference as
previously noted in Table 1. Outcomes are displayed as pre-operative scores as compared to
post-operative scores at several follow-up time intervals whenever possible. 4 of the studies did
not specify actual pre-operative scores but instead reported findings in terms of mean changes
and differences, benefit percentage points, or post-operative scores only. Some of these studies
did obtain pre-operative scores, but findings were only displayed in tables or graphs and
therefore exact data could not be extracted. Significant improvements in speech scores pre- to
post- operatively were denoted with a “*” in the post-op findings column (p<0.05 or less). If the
finding was not marked with “*”, then the finding was either insignificant or was not specified.
Impression of the finding will be indicated in the significant findings column. Other outcomes
noted in this table include a comparison of EAS verses non- EAS user comparisons. In 9 of 10
studies, researchers included some kind of comparison between the use of the acoustic
component in an EAS system and the use of the CI alone. This comparison may include the
differences between subjects using a traditional CI and those using a Hybrid Device, or a withinsubjects’ comparison of EAS use as compared to no EAS use. Lastly, significance findings were
extracted from each study and were summarized in the final column of the Table 3. If a study did
not state statistical significance, then the overall finding or impression was noted.
The most common speech measure that was used and extracted from the included studies
was CNC words. CNC words consist of open set word lists of monosyllabic words, in which the
structure of consonant- nucleus- consonant is maintained. It is considering the gold standard in
testing cochlear implant candidacy and is therefore frequently used as a pre-operative verses

22

post-operative comparison in this review (Bierer et al., 2016). While all studies included
measurement points up to at least 12 months, exact post-operative scores at the 12-month mark
were not always reported. For that reason, the exact post-operative scores at earlier follow-up
points are reported in Table 3. As previously stated, 5 of 10 studies utilized CNC words as one of
their speech perception outcome measures. 4 of these 5 studies reported both pre-operative and
post-operative scores. Adunka et al., 2013 reported a mean pre-operative score of 23.1%, with
post-operative scores recorded at 65.1% at 3 months, 69.1% at 6 months, and 70.7% at 12
months. All post-operative follow-up points revealed significant improvements in scores from
pre- to post-op. Roland et al., 2016 reported a mean pre-operative score of 28.4%, with a postoperative score of 64.2% at 6 months. Similar findings were noted for 3 month and 12 month
follow up intervals. All post-operative follow-up points revealed significant improvements in
scores from pre- to post-op. Similarly, in Roland et al., 2018, a mean pre-operative score of
27.7% was reported with post-operative scores obtained at 73.4% at 12 months, 69.1% at 3
years, and 70.4% at 5 years. All post-operative follow-up points revealed significant
improvements in scores from pre- to post-op. In Santa Maria et al., 2013, scores were reported
for the implanted ear alone and in the bilateral condition. In the implanted ear alone, preoperative scores were obtained at 15.42%, with early post-op scores at 54.5% and late post-op
scores at 45.83%. In the bilateral condition, pre-operative scores were obtained at 20.29%, with
early post-op scores at 64% and 40%. Significant improvements were noted pre- to post-op at
both follow-up intervals in both conditions. In the 5th study which included CNC words, Gantz et
al., 2016, findings were reported as signficant differences pre- to post-operatively. 87% of
subjects had significant improvements pre- to post-op in the hybrid cochlear implant with a
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contralateral hearing aid condition. 82.5% of subjects had significant improvements pre- to postop in the hybrid cochlear implant alone condition.
Other speech perception tests performed in quiet included the BKB sentences in quiet.
With this measure, Santa Maria et al., 2013 obtained a pre-operative score of 62.8%, with an
early post-op score of 88.5% and a late post-op score of 80% in the implanted ear alone
condition. In the bilateral condition, a pre-op score of 68.4%, a early post-op score of 97.3%, and
a late post-op score of 80.3% were obtained. Both findings were statistically significant. Several
studies utilizes speech perception tests in the local languages. Skarzynski et al., 2014, using
Polish monosyllabic words in quiet, obtained mean pre-operative scores at 35.6%. Post operative
scores were not reported, but significant improvements were noted. It was also reported that 71%
of subjects obtained >20 percentage point gains in word scores. Lenarz et al., 2013 did not note
pre-operative scores but reported a mean benefit of 32 percentage points for the hybrid cochlear
implant ear, which was significant, using disyllabic and monosyllabic words in local languages.
Usami et al., 2014 utilized a speech discrimination test in the local language and obtained a preoperative score of 24.1% and a post-operative score of 67.4% at 12 months which was
statistically significant. Carvalho et al., 2013 utilized a speech perception test based on test
developed by Bevilacqua et al. from several English language tests. An average pre-operative
score for all subjects was obtained at 7.67% and 4.5% for EAS users only. Post-operative scores
were obtained at 63.67% and 72% for all subjects and EAS subjects, respectively. Härkönen et
al., 2017 assessed speech discrimination in quiet and speech perception in noise using disyllabic
Finnish words. No pre-operative scores were reported but they noted an 88% speech
discrimination score and approximately 82% correct at 0dB SNR post-operatively.
Several speech in noise tests were also conducted to determine benefit pre to post-

24

operatively. BKB-SIN is a speech in noise test used in 2 of the studies. Gantz et al., 2016 did not
note pre-operative scores but reported significant changes pre-operatively to post-operatively in
the hybrid cochlear implant with contralateral hearing aid condition and in the hybrid cochlear
implant alone condition. Minimal or non-significant improvements were noted in the electriconly condition. Santa Maria et al., 2013 also utilized BKB-SIN with a score of 9.75 preoperatively and 7.6 post-operatively which was not significant. Adunka et al., 2013 utilized the
CUNY sentences in noise with mean pre-operative score obtained at 15.1%, and post-operative
scores obtained at 23.8% at 3 months, 18.4% at 6 months and 21.5% at 12 months. All score
improvements were significant. Roland et al., 2016 reported AzBio sentences in noise with preoperative scores of 16.3% and post-operative scores of 48.3% in the implanted ear alone at all
follow-up intervals. A significant improvement of 33 percentage points in the bilateral condition
was also noted. Usami et al., 2014 employed several speech in noise measures including
monosyllable perception in noise, word perception in noise, and sentence perception in noise.
Pre-operative scores were obtained at 21%, 35.8% and 51.3% and post-operatively at 60.2%,
77%, and 88.2% at 12 months, respectively for the previously stated measures. Skarzynski et al.,
2014 utilized monosyllabic words in noise but did not report pre-operative scores. They reported
signficiant improvments in scores pre- to post-operatively and 91% of subjects obtained >20
percentage point gains in word scores in noise. Lenarz et al., 2013 also did not report preoperative findngs for speech recognition in noise using disyllabic and monosyllabic words in
local languages. Post-operatively, a mean benefit of 42 percentage points for the hybrid cochlear
implant ear was found, which was significant. Also, 73% of subjects improved their speech
recognition score in noise by ³20 percentage points or ³2 dB SNR. In summary, significant preto post-op improvements were found in all studies which reported significance. Of those studies
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that did not report significance, considerable improvements were found.
9 of the 10 studies also included a comparison of EAS and non-EAS users to determine
the benefit of including an acoustic stimulation of low frequencies, along with the traditional
electric stimulation of the high frequencies. 5 of these 9 studies included a within-subjects’
comparison of performance with and without use of the acoustic component. These subjects
utilized electric stimulation alone without the benefit of acoustic hearing and scores were
compared. Adunka et al., 2013, Gantz et al., 2016 and Usami et al., 2014 all reported
significantly better performance in speech outcome measures using the EAS component as
compared to use of electric stimulation alone. Skarzynski et al., 2014 had similar findings when
testing in noise, but these improvements were not significant in the quiet condition. Lenarz et al.,
2013 reported that the use of the acoustic component of the hybrid cochlear implant resulted in
an average benefit of 20 percentage points or 2dB SNR in quiet and in noise as compared to
cochlear implant alone, however no significance finding was noted. One study performed a
between-subjects’ comparison of EAS use. Härkönen et al., 2017 noted that hybrid cochlear
implant subjects performed better in speech perception tasks as compared to bilateral cochlear
implant and bimodal cochlear implant subjects, but the differences between hybrid cochlear
implant with a contralateral hearing aid subjects and the bilateral cochlear implant subjects were
not significant. The remaining 3 studies which reported comparisons found no significant
differences between those subjects who used EAS and those who did not. Santa Maria et al.,
2013 found that there were no significant differences between those using EAS and those no
longer using EAS in any speech outcome or subjective measure. Those who no longer used EAS
either lost residual hearing post implantation or chose to discontinue use. Carvalho et al., 2013
found that there were no notable differences between users of EAS and non-EAS users. Roland
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et al., 2016 stated that of the 7 subjects who lost residual hearing, but continued to use the
implanted device with electric-only along with a hearing aid in the contralateral ear, had average
bilateral CNC word scores in quiet that were statistically similar to hybrid subjects able to use
acoustic hearing in both ears. Overall, significant pre- to post-operative findings were noted in all
studies and the use of EAS also proved to be of significant benefit in the majority of the studies.
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Table 3: Speech Recognition Outcomes
Study

Speech
Outcome
Measures
CNC words in
quiet (EAS
condition only)

Pre-op Findings
(mean, unless
otherwise noted)
23.1 ± 6.8%.

CUNY
sentences in
noise

Carvalho, G. M. et al.
(2013). Hearing
Preservation after
Cochlear Implantation:
UNICAMP Outcomes.
(Carvalho et al., 2013)

Gantz, B. J., et al.
(2016). Multicenter
clinical trial of the
Nucleus Hybrid S8
cochlear implant: Final
outcomes: S8 Hybrid
Cochlear Implants.
(Gantz et al., 2016)

Adunka, O. F., et al.
(2013). Hearing
preservation and speech
perception outcomes
with electric-acoustic
stimulation after 12
months of listening
experience: Hearing
Preservation and
Speech Perception
Outcomes with EAS.
(Adunka et al., 2013)

Post-op Findings

EAS user vs Non-EAS
User Comparison

Significance Findings

All subjects showed
improved scores using
EAS over CI alone in
all measures, at all time
intervals.

-Subjects had significant
improvements in scores
for CNC words and
CUNY sentences pre- to
post-op.

3 mo
65.1 ±
13.1%*

6 mo
69.1 ±
15.3%*

12 mo
70.7 ±
11.7%*

15.1 ± 11.3%.

61.7 ±
23.8%*

66.6 ±
18.4%*

72.2 ±
21.5%*

Speech
perception test
[based on test
developed by
Bevilacqua et al.
from several
English
language tests]

All subjects- 7.67%
EAS users only4.5%

All subjects- 63.67%
EAS users only- 72%

No notable differences
between EAS and nonEAS users

Overall improvement
between pre- and post-op
scores. Significance
findings not reported.

CNC words in
quiet

Pre-operative scores
not reported; findings
reported in changes
over time

Hybrid CI + Contra HA
87% of subjects had
significant improvements
pre- to post-op*

-Subjects were
compared in 3
conditions; CI only
(electric), hybrid CI
only, and hybrid CI +
HA in contralateral ear.
Subjects showed
significant
improvement in CNC
and BKB-SIN scores in

-Subjects experienced
significant improvements
in CNC and BKB scores
pre- to post-op in both the
hybrid CI and hybrid
CI+HA conditions

Hybrid CI
82.5% of subjects had
significant improvements
pre- to post-op*

-Better scores noted for
EAS condition over CI
alone condition for all
subjects, in all measures,
at all time intervals.
Significance was not
reported

-Subjects yielded the
greatest significant
improvements in CNC and
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CI (electric only)
60% of subjects had
significant improvements
pre- to post-op*
BKB SIN

Pre-operative scores
not reported; findings
reported in changes
over time

Hybrid CI + Contra HA
Significant changes noted
pre- to post-op (P < .0001)*
Hybrid CI
Significant changes noted
pre- to post-op (P < .0001)*
CI (electric only)
Minimal/ non-significant
improvements noted pre- to
post-op

Härkönen, K., et al.
(2017). Hybrid cochlear
implantation: quality of
life, quality of hearing,
and working
performance compared
to patients with
conventional unilateral
or bilateral cochlear
implantation.(Härkönen
et al., 2017)

Speech
discrimination
in quiet using
disyllabic
Finnish words

Pre-operative scores
not reported; findings
reported in figures

88% speech discrimination

Speech
perception in
noise using
disyllabic
Finnish words

Pre-operative scores
not reported; findings
reported in figures

Approximately 82% correct
at 0dB SNR (exact number
not reported)

Lenarz, T., et al. (2013).
European multi-centre
study of the Nucleus
Hybrid L24 cochlear
implant. (Lenarz et al.,
2013)

Speech
recognition in
quiet using
disyllabic and
monosyllabic
words in local
languages

Pre-operative scores
not reported; findings
reported in benefit
percentage points

-Mean benefit of 32
percentage points for the
hybrid CI ear*
-Mean benefit of 28% points
for the best aided condition*
-70% of subjects improved
their speech recognition score
in noise by _³20 percentage
points in CI ear

both the hybrid CI and
hybrid CI+ HA
condition. Nonsignificant changes
were noted in the CI
only condition

BKB-SIN scores pre- to
post- op in the hybrid CI+
HA condition over all
other conditions with no
significant difference in
the CI only condition.

- Greatest
improvements were
noted in the hybrid
CI+HA condition
-No significant changes
noted pre- to post-op
for the CI condition
(electric only) on BKBSIN
-Hybrid CI subjects
performed better in
speech perception tasks
as compared to bilateral
CI and bimodal CI
subjects.
-Differences between
hybrid CI + contra HA
subjects and bilateral CI
subjects were not
significant
-Use of the acoustic
component of the
hybrid CI resulted in an
average benefit of 20
percentage points or
2dB SNR in quiet and
in noise as compared to
CI alone (electric only).
- For 12% of subjects
CI only and hybrid

-Subjects experienced
improvements in speech
discrimination scores, but
nothing can be said
regarding its significance
- Findings indicate
subjects with hybrid CI +
contra HA score better
than bilateral CI subjects,
however, this difference is
not significant
-Subjects experienced a
significant improvement
in speech recognition in
quiet and in noise pre- to
post-op
-Use of EAS resulted in a
substantial benefit for
subjects in speech and in
noise
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Speech
recognition in
noise using
disyllabic and
monosyllabic
words in local
languages

Roland, J. T., et al.
(2016). United States
multicenter clinical trial
of the cochlear nucleus
hybrid implant system:
Nucleus Hybrid
Implant System Clinical
Trial. (Roland et al.,
2016)

CNC words

AzBio sentences
in noise

Roland, J. T., et al.
(2018). Long-term
outcomes of cochlear
implantation in patients

CNC in quiet

Pre-operative scores
not reported; findings
reported in benefit
percentage points

-Mean benefit of 42
percentage points for the
hybrid CI ear*

conditions resulted in
equal scores

-Mean benefit of 38% points
for the best aided condition*

28.4%± 14.7%

16.3% ± 14.4%

Unilateral
27.7%

-73% of subjects improved
their speech recognition score
in noise by _³20 percentage
points or ³2 dB SNR
6 mo post-op
Implanted ear
64.2% ± 26.6%*
similar findings noted for 3
month and 12 month followup intervals*
Bilateral
Improvement of 34.7
percentage points
(SD=17.4)*
Implanted ear
48.3% ± 31.3%*
similar findings noted for 3
month and 12 month followup intervals*
Bilateral
Improvement of 33
percentage points
(SD=23.5)*
12 mo
73.4%*

3 yrs
69.1%*

5 yrs
70.4%*

Of the 7 subjects who
lost residual hearing but
continued to use the
implanted device,
electric-only (along
with a hearing aid in the
contralateral ear),
average bilateral CNC
word scores in quiet
were statistically
similar to hybrid
subjects able to use
acoustic hearing in both
ears *

--

-96% and 90% of subjects
performed equal or better
on CNC words and AzBio
sentences as compared to
pre-operative scores.
-All subjects had a
significant improvement
in CNC words and AzBio
sentences pre- to post-op
-Significant improvements
were also found in the
bilateral (EAS+ HA in
contralateral ear)
condition
-EAS and non-EAS users
has statistically similar
CNC word scores in quiet
-Subjects experienced
significant improvements
in CNC scores pre-op to
post-op.
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with high-frequency
hearing loss: LongTerm Electric-Acoustic
Hearing Outcomes.
(Roland et al., 2018)
Santa Maria, P. L., et
al. (2013). Hearing
Preservation Surgery
for Cochlear
Implantation—Hearing
and Quality of Life
After 2 Years.
(Santa Maria et al.,
2013)

Skarzynski, H., et al.
(2014). Cochlear
Implantation with the
Nucleus Slim Straight
Electrode in Subjects
with Residual LowFrequency Hearing.
(Skarzynski et al., 2014)

Bilateral
45.8%

83.5%*

Implanted ear
62.8%

Early post-op
88.5%*

Late post-op
80%*

Bilateral
68.4%

97.3%*

80.8%

Implanted ear
15.42%

54.5%*

45.83%*

Bilateral
20.29%

64%*

40%*

BKB SIN (EAS
users only n=4)

9.75

7.6

Polish
monosyllabic
words in quiet
Polish

35.6%

Significant improvement in
word scores pre- to post op*

BKB sentences
in quiet

CNC words in
quiet

Monosyllabic
words in noise
(+10dB SNR)

Pre-operative score
not reported; findings
reported in mean
differences

80.3%*

-No significant changes in
scores from the 12 month
point other measurement
intervals

80.4%*

There were no
significant differences
between those using
EAS and those no
longer using EAS in
any speech outcome or
subjective measure

71% of subjects obtained >20
percentage point gains in
word scores

-Use of EAS + contra
HA resulted in
significantly better
performance in noise as
compared to CI only +
contra HA*

Significant improvement in
word scores in noise pre- to
post op*

-In quiet, improvements
in scores were nonsignificant

91% of subjects obtained >20
percentage point gains in
word scores in noise

-All subjects had a
significant improvement
in BKB sentences and
CNC words pre- to postop
-Overall, subjects had a
better signal to noise ratio
post-op on BKB SIN. No
significant positive
changes were noted.
-No significant differences
in speech outcomes
between EAS and nonEAS users
-Subjects achieved
significant improvement
in scores for words in
quiet and words in noise
-Use of EAS as compared
to electric only CI,
significantly improved
word recognition in noise
but not in quiet
-Subjects with all degrees
of pre-operative HL
obtained equal substantial
gain in quiet, however, in
noise, subjects with the
better pre-operative
hearing achieved greater
sore gains.
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Usami, S.-I., et al.
(2014). Hearing
preservation and
clinical outcome of 32
consecutive electric
acoustic stimulation
(EAS) surgeries.
(Usami et al., 2014)

Speech
discrimination

24.1%

1 month
48.4%

12 months
67.4%*

Monosyllable
perception in
noise

21.0%

36.9%

60.2%*

Word perception
in noise

35.8%

--

77.0%*

Sentence
perception in
noise

51.3%

--

88.2%*

-EAS resulted in the
significantly better
performance in speech
discrimination and
monosyllable, word,
and sentence perception
in noise as compared to
the acoustic stimulation
only and electric
stimulation only
conditions*

-Subjects experienced
significant improvements
in speech discrimination
as well as monosyllable,
word, and sentence
perception in noise pre- to
post-op
-Use of EAS significantly
improved subject’s speech
discrimination and
perception abilities over
electric stimulation or
acoustic stimulation alone

-Similar results were also
obtained for those subjects
with less residual hearing
BKB-SIN: Bamford-Kowal-Bench Speech-in-Noise test; BKB sentences: Bamford-Kowal-Bench sentences; CI: Cochlear implant; contra: contralateral; CNC
words: Consonant- Nucleus- Consonant words; CUNY: City University of New York; HA: Hearing Aid

*Denotes a significance (p<0.05 or less) finding from pre-op unless otherwise noted
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Subjective Outcomes
Another outcome measure extracted from the included studies in this review were
subjective outcome reports. Subjective outcomes refer to the perceived benefit of the subjects
and are measured based on patient report. 70% (7 of 10) studies reported subjective outcome
measures using a variety of different materials. The most common measure used was the Speech,
Spatial and Qualities of Hearing Scale (SSQ), which was utilized in 4 of the 7 studies. The
questionnaire aims to assess a range of hearing disabilities across 3 domains with particular
attention given to hearing speech in a competing context, direction and distance of hearing in
space, and the quality of hearing experience (Gatehouse & Noble, 2004). Roland et al., 2016,
Roland et al., 2018 and Lenarz et al., 2013 all found significant subjective improvements in
speech, spatial, and quality subscales pre- to post-operatively for a within-subject comparison. 1
of the 4 studies which used the SSQ, compared hybrid cochlear implant users to bilateral
cochlear implant and single-sided deafness (SSD) patients. Härkönen et al., 2017 noted that
bilateral CI patients experienced significantly better speech intelligibility than hybrid CI or SSD
patients. This same study also administered the Glasgow Benefit Inventory (GBI) which found
that subjects experienced significant subjective benefit in general health and overall GBI score
and that hybrid cochlear implant subjects experienced overall greater significant benefits than
SSD patients. Subjective benefit was not significant in the social support and physical health
sub- categories. Other subjective outcome measures included hearing aid benefit questionnaires
utilized to represent benefit from cochlear implantation. Using the Abbreviated Profile of
Hearing Aid Benefit (APHAB), Santa Maria et al., 2013 found that subjects experienced
significant perceived benefit in global benefit, background noise, and reverberation, but nonsignificant benefit was noted in ease of communication and aversiveness subscales. The
differences between EAS and non-EAS users experience were not significant. Gantz et al., 2016
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reported that subjects had >22% improvement in 3 of 4 subscales; background noise, ease of
communication, and reverberation. They concluded that subjects experienced significant
perceived benefit in background noise, ease of communication, and reverberation. Santa Maria et
al., 2013 also utilized the Glasgow Hearing Aid Benefit Scale (GHABP) which showed high
levels of use and benefit, as well as low levels of residual disease, but no statement was made for
the satisfaction subscale. The difference between EAS and non-EAS users was, again,
insignificant. Lenarz et al., 2013 also included a second subjective outcome measure of the
Health Utility Index mk3 (HUI). The study indicated that subjects had significant improvements
in health related quality of life scores. Lastly, Carvalho et al., 2013 utilized a quality of
experience rating using the Likert scale in which 0 indicated that the user regretted using the CI
intervention or would not recommend it and 10 indicated that the user was completely satisfied
with the CI intervention. At the time of reporting, only 4 of 6 subjects utilized EAS. A “*” was
denoted on individual subjects to indicate that they were not EAS users. All EAS users reported
an 8 out of 10 or better on the Likert scale suggesting high satisfaction with the CI intervention.
Overall, subjects experienced significant subjective improvements in a number of subscales and
contexts across all studies included in this review.
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Table 4: Subjective Outcome Measures
Study

Adunka, O. F., et al. (2013).
Hearing preservation and speech
perception outcomes with electricacoustic stimulation after 12
months of listening experience:
Hearing Preservation and Speech
Perception Outcomes with EAS.
(Adunka et al., 2013)
Carvalho, G. M. et al. (2013).
Hearing Preservation after
Cochlear Implantation: UNICAMP
Outcomes.
(Carvalho et al., 2013)
Gantz, B. J., et al. (2016).
Multicenter clinical trial of the
Nucleus Hybrid S8 cochlear
implant: Final outcomes: S8
Hybrid Cochlear Implants. (Gantz
et al., 2016)
Härkönen, K., et al. (2017). Hybrid
cochlear implantation: quality of
life, quality of hearing, and
working performance compared to
patients with conventional
unilateral or bilateral cochlear
implantation.(Härkönen et al.,
2017)

Subjective Outcome Measure

Subjective Outcome Score
(mean changes pre- to post-op unless
otherwise noted)

Significance Findings

--

--

--

Quality of experience rating using
Likert scale
[0 indicated user regretted the CI
intervention/would not
recommend; 10 indicated user was
completely satisfied with CI
intervention]
Abbreviated Profile for Hearing
Aid
Benefit (APHAB)

Subject 1- 9
Subject 2- 6*
Subject 3- 9*
Subject 4- 10
Subject 5- 10
Subject 6- 8

All EAS users reported an 8 out of
10 or better on the Likert scale
suggesting high satisfaction with
CI intervention

>22% improvement in 3 if 4 subscales;
background noise, ease of communication,
reverberation (reasonable estimate of the
critical differences at a 90% confidence
interval)

Subjects experienced significant
perceived benefit in background
noise, ease of communication, and
reverberation

Glasgow Benefit Inventory (GBI)

Mean total GBI score- +44 (p=.012)
General health- +68 (p=0.011)
Social support- +2 (not significant)
Physical health- -10 (not significant)
Mean total GBI statistically significantly
higher for hybrid CI patients than for SSD
patients (p=0.012)
Subject subscale score; mean change not
reported
Speech- 5.4
Spatial- 5.5
Quality- 6.2

-Subjects experienced significant
subjective benefit in general
health and overall GBI score.

Speech, Spatial and Qualities of
Hearing Scale (SSQ)

-Hybrid CI subjects experienced
overall greater significant benefits
than SSD patients.
Bilateral CI patients experienced
significantly better speech
intelligibility than hybrid CI or
SSD patients.
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Lenarz, T., et al. (2013). European
multi-centre study of the Nucleus
Hybrid L24 cochlear implant.
(Lenarz et al., 2013)

Speech and spatial qualities scale
(SSQ)

Speech- 1.2 (p<0.001)
Spatial- 1.3 (p<0.001)
Quality- 1.8 (p<0.001)

Healthy Utility Index mk3 (HUI)

Multi-attribute HUI3- +0.117 (p < 0.01,
effect size Cohen’s d=0.67)

Roland, J. T., et al. (2016). United
States multicenter clinical trial of
the Cochlear Nucleus Hybrid
implant system: Nucleus Hybrid
Implant System Clinical Trial.
(Roland et al., 2016)
Roland, J. T., et al. (2018). Longterm outcomes of cochlear
implantation in patients with highfrequency hearing loss: Long-Term
Electric-Acoustic Hearing
Outcomes. (Roland et al., 2018)

Speech, Spatial and Qualities of
Hearing Scale (SSQ)

Speech- 2.2 (SD= 1.8, p<0.001)
Spatial- .9 (SD= 2.0, p<0.003)
Quality- 1.3 (SD=2.0, p<0.001)

Speech, Spatial and Qualities of
Hearing Scale (SSQ)

Significant pre- to post differences; Actual
score differences not reported
Speech- p<.001 for 12 months, 3 years,
and 5 years post-activation.
Spatial- p<.001 for 12 months postactivation; p<0.02 for 3 years and 5 years
post- activation.
Quality- p<.001 for 12 months, 3 years,
and 5 years post-activation.

Subjects experienced significant
subjective improvements in
speech, spatial, and quality
subscales, which remained stable
across post-activation intervals

Santa Maria, P. L., et al. (2013).
Hearing Preservation Surgery for
Cochlear Implantation—Hearing
and Quality of Life After 2 Years.
(Santa Maria et al., 2013)

Abbreviated Profile of Hearing
Aid Benefit (APHAB)

Global- 19.87 (p=.02)
Ease of communication- 22.97 (not
significant)
Background noise- 18.13 (p=.03)
Reverberation- 18.57 (p<.01)
Aversiveness-2.77 (not significant)

-Subjects experienced significant
perceived benefit in global benefit,
background noise, and
reverberation.

Glasgow Hearing Aid Benefit
(GHABP Scales)

Mean scores; only measured post-op
Use- 87.4
Benefit- 63.3
Residual disease- 58.6
Satisfaction- 55.1

Subjects experienced significant
subjective improvements in
speech, spatial, and quality
subscales
Subjects experienced significant
improvements in health related
quality of life scores.
Subjects experienced significant
subjective improvements in
speech, spatial, and quality
subscales

-Non-significant benefit was noted
in ease of communication and
aversiveness subscales.
-Differences between EAS and
non-EAS users were not
significant
- The GHABP scores showed high
levels of use, benefit, and low
levels of residual disease. No
statement made regarding
satisfaction
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- Differences between EAS and
non-EAS users were not
significant
Skarzynski, H., et al. (2014).
Cochlear Implantation with the
Nucleus Slim Straight Electrode in
Subjects with Residual LowFrequency Hearing.
(Skarzynski et al., 2014)
Usami, S.-I., et al. (2014). Hearing
preservation and clinical outcome
of 32 consecutive electric acoustic
stimulation (EAS) surgeries.
(Usami et al., 2014)

--

--

--

--

--

--

*Denotes subjects were not EAS/hybrid users
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Hearing Preservation Outcomes
All of the 10 studies in this review included data regarding hearing preservation
following the implant surgery. Hearing preservation was a topic of discussion in all of the studies
as the degree of preserved hearing determined the ability to use electric acoustic stimulation with
a hybrid implant system. Hearing preservation in all studies was in reference to the ability to
maintain thresholds of hearing in the low frequency range, typically between 125-1000Hz. Going
forward, discussion of hearing preservation is in reference to this low frequency hearing range.
Table 5 displays extracted information regarding hearing preservation in the 10 studies. As each
of the studies specified different amounts of hearing preservation, defined degrees were included
in this table for ease of reference as previously stated in Table 1. Extracted information included
the mean pre-operative low frequency pure tone average (LF PTA), the post-operative low
frequency pure tone average specified by frequency and/or follow-up interval, the percentage of
subjects who maintained some degree of functional or partial hearing preservation, and the
number of subjects who experienced a total loss or non-functional loss of hearing. Lastly, 4 of
the 10 studies included subject’s continued use of the EAS system at least one-year postimplantation.
Low frequency pure tone averages were reported in a number of ways. Adunka et al.,
2013, Gantz et al., 2016, Härkönen et al., 2017, and Lenarz et al., 2013 reported the mean low
frequency pure tone average for all subjects. Mean low frequency PTA was 44.7dB HL, 48.9dB
HL, 18dB HL, and 46.7 dB HL for the stated studies, respectively. Skarzynski et al., 2014,
Usami et al., 2014, and Adunka et al., 2013 reported mean low frequency thresholds by
frequency. Between these studies the mean threshold was 36.6dB HL at 250Hz, 57.25dB HL at
500Hz, and 86.4dBHL at 1000Hz. These averages follow the general trend of a sharply sloping
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hearing loss which is of a more mild degree in the lowest freqencies, sloping to more severe
towards the mid-frequencies. Roland et al., 2016 and Roland et al., 2018 reported low frequency
PTA by their degree of hearing loss. See Table 5 for specific numbers of subjects in each hearing
loss category. Santa Maria et al., 2013 reported all subject’s low frequency thresholds were less
than 65dB at thresholds below 500Hz. Carvalho et al., 2013, due to their small sample size,
reported average low frequency pure tone average by subject. Averages ranged from 48.3-75dB
HL.
Studies reported hearing preservation in a number of ways in order to demonstrate how
much hearing was maintained and lost following cochlear implant surgery. Several studies chose
to report the post-operative low frequency pure tone average to express these changes. Adunka et
al., 2013 reported a mean low frequency PTA of 44.7dB HL pre-opertively, declining to 60.6dB
HL one month post-op and 68.5dB HL 12 months post-op, overall concluding that 94.4% of
subjects maintained at least partial hearing preservation at initial activation. Gantz et al., 2016
also reported a mean low frequency PTA of 48.9dB HL pre-op, declining to 63.6dB HL at one
month post-op, further noting that another smaller decline occurred in the first 3 months which
then stabilized going forward. They stipulated that 94% of the subjects maintained functional
hearing from 125 to 500 Hz at initial activation. Similarly to these studies, Usami et al., 2014
reported a mean low frequency PTA of 50.13dB HL pre-op, to 66.15dB HL one month post-op
and 68.14dB HL 12 months post-op, indicating that 93.3% of subjects maintained sufficient
residual low frequency hearing for EAS. Härkönen et al., 2017 reported the mean decline in
hearing in the implanted ear with an average of an 11dB HL decrease in threshold at 125Hz,
14dB HL at 250Hz, and 19dB HL at 500Hz. Mean low frequency PTA decline was 15dB HL
post-operatively. At the end of follow-up, researchers concluded that 87.5% of subjects
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maintained preserved low frequency residual hearing. Similarly, Skarzynski et al., 2014 reported
that at 1 month post-op, the average low frequency PTA declined by 10dB HL and 15dB HL by
12 months. This study also noted that at 1 month, 43% of subjects had preserved hearing within
10dB HL of pre-op values and 86% had preserved hearing within 30dB HL. At 12 months these
numbers declined with 38% of subjects preserving hearing within 10dB HL and 79% preserving
within 30dB HL. Overall, 91% of subjects maintained some degree of residual hearing at 1
month post-op. Additionally, Roland et al., 2016 reported post-op hearing preservation by the
number of subjects whose low frequency PTA fell within a specified hearing range. Postoperatively, 15 out of 48 subjects (31.25%) fell in the 41-55dB HL loss range, 9 of 48 subjects
(18.8%) fell in the 56-70dB HL loss range, and 9 of 48 subjects (18.8%) fell into the 71-90dB
HL loss range. 66% of subjects maintained residual functional acoustic hearing at 6 months’
post-activation. The remaining studies in this review chose to report post-operative low
frequency thresholds in terms of their own pre-determined degrees of hearing preservation.
Individal studies defined categories of hearing preservation can be located in Table 1 and again
in Table 5. Carvalho et al., 2013 stipulated that at initial activation and after more that 1 year
post-op, 1 subject maintained total hearing preservation, 3 subjects achieved partial hearing
preservation, 2 subjects experienced hearing preservation failure. This indicated 66.7% of
subjects maintained some degree of functional hearing for EAS use at the initial activation and
more than 1 year post-operatively. Lenarz et al., 2013 reported that at 1 month post-op, 61% of
subject’s hearing was completely conserved and 89% of subject’s hearing was partially or
completely conserved. At 12 months, 43% of subject’s hearing was completely conserved (-18%
points) and 74% of subject’s hearing was partially or completely conserved (-15% points). They
determined that 98% of subjects maintained residual hearing at 500Hz 1-month post-op and 88%
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maintained residual hearing at 500Hz 12 months post-op. Lastly, Roland et al., 2018 and Santa
Maria et al., 2013 reported degrees of hearing preservation past the 12 month follow-up period.
Roland et al., 2018 found that 84.4% of subjects maintained function hearing at 6 months postop, 87.5% at 12 months, 87.5% at 3 years, and 87.5% at 5 years. They also noted that the pre- to
post- operative low frequency pure tone average differences were statistically significant but low
frequency PTA changes 6 months to 5 years were not statistically significant. Santa Maria et al.,
2013 concluded that hearing preservation somewhat declined over time, however, even by 24+
months post-op, 87.5% experienced some degree of hearing preservation.
All studies reported the number of subjects who experienced a total loss of hearing or not
enough hearing was preserved to be considered “functional” following the cochlear implant
surgery. Only one study, Lenarz et al., 2013, reported 0 subjects had a total loss of hearing.
Remaining studies reported that between 5% and 33.3% of subjects experienced a total or nonfunctional loss of hearing. Of the studies which reported specific numbers of subjects rather than
percentages, between 1 and 16 subjects did not maintain functional hearing. It should be noted
that the range of these statistics are heavily influenced by sample size. Overall the studies found
that the vast majority of subjects achieved hearing preservation to varying degrees.
Lastly, as some subjects historically discontinue use of the EAS system over time, EAS
usage at > 1 year after activation was reported in 4 of the 10 studies. Generally, subjects may
choose to discontinue use due to a number of factors. A common reasoning is that the subjects
had a further decline in hearing in the months following surgery. For that reason, these subjects
were no longer a candidate for electric acoustic stimulation. In Carvalho et al., 2013, the 4
subjects who used EAS at activation continued use more than 1 year post op. According to
Lenarz et al., 2013, 88% of subjects continued use at 1 year post-op. In Roland et al., 2018, EAS
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usage was reported at 12 months, 3 years, and 5 years post-activation to demonstrate continued
use over time. Usage was 84%, 81%, and 72%, respectively at the specificed follow-up periods,
showing a slight but insignificant decline in usage over time. Moreover, Santa Maria et al., 2013
reported the greasted decline in usage over time with only 6 of 11 patients utilizing EAS at 18
months after activation. Overall, studies maintained good usage of EAS systems at more than 1
year after implanation, with the majority of subjects continuing use.
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Table 5: Hearing Preservation Outcomes
Study

Adunka, O. F., et al.
(2013). Hearing
preservation and speech
perception outcomes with
electric-acoustic
stimulation after 12
months of listening
experience: Hearing
Preservation and Speech
Perception Outcomes
with EAS. (Adunka et al.,
2013)
Carvalho, G. M. et al.
(2013). Hearing
Preservation after
Cochlear Implantation:
UNICAMP Outcomes.
(Carvalho et al., 2013)

LF Hearing
Preservation
Defined by
Study

Pre-op Low
Frequency Pure
Tone Average
(mean unless
otherwise
specified)

Partial Hearing
Preservation;
Total Hearing
Loss

44.7 ± 16.5 dB
HL [MEAN LF
PTA];
32.5 ±12.0
dB HL [250 Hz];
56.4 ± 11.1 dB
[750Hz]

1 mo post-op
60.6 ± 16.1
dB HL
[MEAN LF
PTA]
45.0 ± 16.7
dB HL
[250Hz]
79.1 ± 9.2 dB
HL [750Hz]

Total hearing
preservation: a
postoperative
unaided hearing
loss of 0–10 dB
Partial hearing
preservation:
postoperative
unaided hearing
loss of >10 dB
but ≤80 dB
hearing or better
in at least one
frequency
between 250 and
1000 Hz

[LF PTA 2501kHz]
Subject 1
65 dBHL

At initial activation and
after >1 year post-op
1 subject maintained total
hearing preservation;
3 subjects achieved partial
hearing preservation;
2 subjects experienced
hearing preservation failure

Subject 2
71.6 dBHL
Subject 3
48.3 dBHL
Subject 4
75 dBHL
Subject 5
66.6 dBHL

Post-op Low Frequency
Hearing

1 yr post-op
68.5 ± 21.7
dB HL
[MEAN LF
PTA]
85.0 ±14.9
dB HL
[750Hz]

Functional or
Partial Hearing
Preservation
Maintained

Total or NonFunctional
Hearing Loss

EAS Usage
PostActivation

94.4% of
subjects
maintained at
least partial
hearing
preservation at
initial activation
(17 of 28)

5% of subjects
had total hearing
loss (1 of 18)

--

66.7% of
subjects
maintained some
degree of
functional
hearing for EAS
use at initial
activation and >1
year post-op (4
of 6)

33.3% of subjects
experienced a
profound or nonfunctional hearing
loss both at initial
activation and >1
year post-op (2 of
6)

4/6 subjects
continued use
of EAS at >1
year post-op
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Gantz, B. J., et al. (2016).
Multicenter clinical trial
of the Nucleus Hybrid S8
cochlear implant: Final
outcomes: S8 Hybrid
Cochlear Implants.
(Gantz et al., 2016)

Härkönen, K., et al.
(2017). Hybrid cochlear
implantation: quality of
life, quality of hearing,
and working
performance compared
to patients with
conventional unilateral or
bilateral cochlear
implantation. (Härkönen
et al., 2017)

Hearing
preservation
failure: unaided
postoperative
thresholds
are >80 dB
Functional
hearing
preservation:
<85-90 dBHL
PTA of 125 to
1kHz [LFPTA];
Non-functional
hearing
preservation:
>90 dB LFPTA;
Total loss of
hearing:
>130dBHL

Subject 6
58.3 dBHL

48.9 dB HL
[mean PTA 1251kHz]

63.6 dB HL LFPTA at 1month post-op (mean decline
of 14.8 dB HL);
*second smaller change
noted in first 3 months,
hearing then stabilized during
remainder of trial (number
not reported)

94% of the
subjects
maintained
functional
hearing from 125
to 500 Hz at
initial activation
(85 of 87)

19.6% of subjects
had nonfunctional LFPTA
at the 12 month
evaluation (16
subjects)

--

Mean LF
hearing
threshold decline
125-500Hz in the
implanted ear;
Total loss of
residual lowfrequency
hearing

Mean LF PTA
was
approximately
18dBHL
*exact number
not reported;
thresholds
obtained from
fig. 2

Mean decrease in hearing in
implanted ear:
at 125Hz: 11dBHL
at 250Hz: 14dBHL
at 500Hz: 19dBHL
mean PTA 125-500Hz:
15dBHL

87.5% of
subjects
maintained
preserved LF
residual hearing
at the end of
follow-up (7 of 8
subjects; or 9 of
10 ears)

12.5% subject
experienced total
loss of residual
hearing (1 of 8)

--
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Lenarz, T., et al. (2013).
European multi-centre
study of the Nucleus
Hybrid L24 cochlear
implant. (Lenarz et al.,
2013)

Completely
conserved:
defined as less
than or equal to
10 dB LF
threshold
increase;
Partially or
completely
conserved:
defined as less
than or equal to
30 dB LF
threshold
increase;
Maintained
residual hearing:
defined as
<90dB LF HL

46.7 dB HL
[125-500Hz]

1-mo post-op
61% of
subjects
hearing was
completely
conserved
89% of
subjects
hearing was
partially or
completely
conserved

Roland, J. T., et al.
(2016). United States
multicenter clinical trial
of the cochlear nucleus
hybrid implant system:
Nucleus Hybrid Implant
System Clinical Trial.
(Roland et al., 2016)

Profound
hearing loss:
greater than
90dBHL;
Functional
acoustic
hearing: less
than or equal to
90dBHL

0–25 dB HL:
1/50 (2.0%);
26 - 40 dB HL:
13/50 (26.0%);
41–55 dB HL:
26/50 (52.0%);
56 - 70 dB HL:
10/50 (20.0%)

Roland, J. T., et al.
(2018). Long-term
outcomes of cochlear
implantation in patients
with high-frequency
hearing loss: Long-Term
Electric-Acoustic
Hearing Outcomes.
(Roland et al., 2018)

Functional
Residual
hearing: defined
as 5 frequency
LF PTA [1251kHz] greater
than or equal to
90 dBHL

26–40 dB HL: 9
subjects
41–55 dB HL:
16 subjects
56–70 dB HL: 7
subjects

1-yr post op
43% of
subject’s
hearing was
completely
conserved (18% points)
74% of
subject’s
hearing was
partially or
completely
conserved (15% points)

98% of subjects
maintained
residual hearing
at 500Hz 1month post-op;
88% of subjects
maintained
residual hearing
at 500Hz 12
months post-op

No subjects
reportedly
experienced
significant/ total
loss of hearing

At one year
post-op,
88% of cases
used
combined
electric and
residual
acoustic
hearing in the
implant ear

LF PTA 6 months postactivation (of subjects who
maintained functional
hearing)
41–55 dB HL: 15/48
(31.25%);
56 - 70 dB HL: 9/48 (18.8%);
71-90 dB HL: 9/48 (18.8%);

66% of subjects
maintained
residual
functional
acoustic hearing
at 6 months postactivation (33 of
50)

30% experienced
profound or total
hearing loss (15
of 50)

--

Functional Hearing 6 months
post-activation: 84.4% of
subjects

Pre- to postoperative LF
PTA differences
were statistically
significant
(p<0.0001);
LF PTA changes
6 months to 5
years were NOT

6% of subjects at
5 years postactivation (2 of
32)

At 12 month
postactivation: 27
or 32 subjects
(84%);
At 3 years
postactivation 26
of 32 (81%);

Functional Hearing 12
months post-activation:
87.5% of subjects
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Santa Maria, P. L., et al.
(2013). Hearing
Preservation Surgery for
Cochlear Implantation—
Hearing and Quality of
Life After 2 Years. (Santa
Maria et al., 2013)

Measurable
hearing: defined
as any
measurable
threshold within
that frequency
range
Total Loss:
defined as no
measurable
thresholds at the
limits of the
equipment
Complete
hearing
preservation (025%);
Partial hearing
preservation (2560%);
Minimal hearing
preservation
(>60%);
Complete loss of
hearing (no
measurable
hearing)

Functional Hearing 3 years
post-activation: 87.5% of
subjects

statistically
significant
(p>0.05)

At 5 years
postactivation 23
of 32 (72%)

Functional Hearing 5 years
post-activation: 87.5% of
subjects

<65dB HL at
frequencies
<500Hz

< 3 months post-op
Complete hearing
preservation: 42.9%
Partial: 50%
Minimal: 7.1%
6 to 12 months post-op
Complete hearing
preservation: 22.2%
Partial: 66.7%
Minimal: 11.1%
12 to 24 months post-op
Complete hearing
preservation: 33.3%
Partial: 22.2%
Minimal: 44.4%
>24 months post-op
Complete hearing
preservation: 25%
Partial: 12.5%
Minimal: 37.5%
Complete loss: 12.5%

100% hearing
preservation at
<3 months postop; 87.5%
experiences
some degree of
hearing
preservation
at >24 months
post-op

12.5% of subjects
experienced
complete loss of
hearing at >24
months post-op

6 of 11
patients were
still utilizing
EAS 18
months postactivation
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Skarzynski, H., et al.
(2014). Cochlear
Implantation With the
Nucleus Slim Straight
Electrode in Subjects
With Residual LowFrequency Hearing.
(Skarzynski et al., 2014)

Average
decrease in
hearing at 125,
250, and 500Hz.
(1) preserved
within 10dB of
pre-op values
(2) preserved
within 30dB of
pre-op values

Usami, S.-I., et al. (2014).
Hearing preservation and
clinical outcome of 32
consecutive electric
acoustic stimulation
(EAS) surgeries. (Usami
et al., 2014)

Average change
in threshold 1251000Hz from
pre-op to 12month post-op

Group 1
250Hz: 27.7
(10.3 SD)
500Hz: 32.3
(13.1 SD)
1000Hz: 68.2
(22.1 SD)
Group 2
250Hz: 45.8
(14.8 SD)
500Hz: 63.8 (8.2
SD)
1000Hz: 91.9
(14.9 SD)
Group 3
250Hz: 66.8
(18.5 SD)
500Hz: 90.5
(12.1 SD)
1000Hz: 102.3
(8.8 SD)
27.5dB HL at
125Hz;
35.5dB HL at
250Hz;
52.3dB HL at
500Hz;
85.2dB HL at
1000Hz

1 mo post-op
- Average LF
PTA decline
of 10dB HL
- 43% of
subjects had
preserved
hearing
within 10dB
HL
- 86% of
subjects had
preserved
hearing
within 30dB
HL

1 yr post-op
-Average LF
PTA decline
of 15dB HL
- 38% of
subjects had
preserved
hearing
within 10dB
HL
- 79% of
subjects had
preserved
hearing
within 30dB
HL

91% of subjects
maintained some
degree of
residual hearing
1 month post-op

9% subjects
experienced total
loss of functional
hearing at 1 year
post-op (3
subjects)

--

1 mo post-op
40.3 dB HL
at 125Hz;
53.8 dB HL
at 250Hz;
76.7 dB HL
at 500Hz;
93.8 dB HL
at 1000Hz

1 yr post-op
41.9 dB HL
at 125Hz;
55.2 dB HL
at 250Hz;
79.8 dB HL
at 500Hz;
96.7 dB HL
at 1000Hz

93.3% of
subjects
maintained
sufficient
residual LF HL
for EAS

7% subjects
experienced loss
of hearing that
was not sufficient
to utilize acoustic
stimulation (2 of
30)

--

Mean:
50.13dB HL

Mean:
66.15dB HL

Mean:
68.4dB HL

HL: Hearing Loss; LF: Low Frequency; LF PTA: Low Frequency Pure Tone Average; PTA: Pure Tone Average; SD: Standard Deviation

47

Discussion
The primary purpose of this investigation was to perform a systematic review of the
current literature regarding users of hybrid cochlear implantation and their speech recognition
outcomes, as well as subjective performance. Degrees of hearing preservation following cochlear
implant surgery was also extracted and analyzed.
In total, ten studies were included in this review which yielded a total overall sample size
of 326 subjects with an average sample size of 32.6. Speech recognition outcomes were assessed
using several materials and measures. The most common speech measure in quiet was CNC
words, used in five of the ten studies. Adunka et al., 2013, Gantz et al., 2016, Roland et al., 2016,
Roland et al., 2018, and Santa Maria et al., 2013 all concluded significant improvements in CNC
speech scores from pre-operatively to post-operatively. Other speech measures in quiet
performed in the remaining studies, again, yielded significant post-operative score
improvements. This is suggestive of significant benefit from cochlear implantation in this
population. The two remaining studies, Härkönen et al., 2017 and Carvalho et al., 2013, reported
overall improvments in scores, but nothing was reported regarding the significance of these
differences. As the vast majority of subjects in these studies experienced a positive improvement,
one can assume that the benefit was favorable.
Other than CNC words, 15 other speech measures were used to assess speech outcomes.
The majority of the studies chose to use some kind of speech in noise measure to assess benefit
in more difficult listening situations. Speech in noise tends to be a frequently reported complaint
for both cochlear implant and hearing aid users. As previously noted in the introduction of this
review, recent research has proposed that the use of acoustic cues in low frequency hearing may
improve speech understanding in noise. The proposed reasoning is that users can take advantage
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of the acoustic cues that are not preserved in traditional cochlear implant speech processing
strategies. Eight of the ten studies included a speech in noise measure, while six of those eight
studies reported significant improvements in words and sentences in noise, pre-operatively to
post-operatively (Adunka et al., 2013, Gantz et al., 2016, Lenarz et al., 2013, Roland et al., 2016,
Skarzynski et al., 2014, Usami et al., 2014). Härkönen et al., 2017, as previously stated, did not
report significance findings but noted a high level of achievement in challenging speech in noise
conditions. Whereas Santa Maria et al., 2013 stated that subjects had an overall better signal to
noise ratio in their speech in noise measure, but this difference was not significant.
To better assess the use of acoustic hearing in cochlear implantation, nine of the studies
included a comparison of EAS verses no EAS use. In the process, the studies attempted to
demonstrate the benefit the acoustic component provided. How they chose to report said benefit
varied greatly and, in turn, mixed findings were noted in terms of signficant benefit. Four studies
reported that the use of the acoustic component yielded a significant improvement in speech
scores, while three studies reported that there was substantial improvement but no significance
was reported. Lastly, two studies noted that there were no notable differences between those
subjects utilizing EAS and those who used traditional cochlear implantation.
Based on the previously noted conclusions, research question one, “Does electric acoustic
stimulation (EAS) through the use of hybrid cochlear implants improve speech recognition
outcomes in adults? If so, to what degree?”, may be addressed. Subjects in all studies
experienced positive improvements from hybrid cochlear implantation. The degree to which they
benefitted varied, but was overall significant pre- to post-operatively. Based on these findings it
may be concluded that these individuals, who would not have been traditional cochlear implant
candidates, are seeing significant positive changes post-implantation. As a secondary finding of
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interest, we may also conclude that the benefit of the acoustic component is difficult to quantify,
but the majority of studies experienced some degree of benefit from the use of EAS. These are
favorable conclusions for the proposed recommendation of expanding cochlear implant
candidacy criteria.
A secondary outcome measure extracted in this review was subjective performance using
a number of materials and measures. The SSQ was by far the most common subjective measure
used amongst the seven studies which included such analysis. Overall, subjects experienced a
significant positive subjective benefit from cochlear implantation in a number of subscales. In
reference to research question two, “What were the subjective improvements experienced by the
EAS subjects on qualitative outcome measures?”, the impression of the extracted information
suggests that patients subjectively report a high level of satisfaction and benefit after going
through with implantation. In a patient centered field, subjective report from amplification users
is essential in promoting an initiative of expanded candidacy.
Hearing preservation was also a topic of particular interest in this study. One of the
emerging subjects of research in this field is the improvement of surgical techniques in order to
better preserve residual low frequency hearing during cochlear implant surgery. These “soft”
surgical techniques, as they are called, have improved substantially in recent years with the
growing popularity of hybrid cochlear implants. While hearing preservation outcomes have
improved, there is still much room for growth before surgeons are able to achieve total
preservation in these candidates. For this reason, degree of hearing maintained after surgery was
reported in all studies in this review and was summarized in Table 5. Of particular interest in
these studies is the ability to preserve enough “functional” hearing. “Functional” hearing refers
to low frequency threshold levels that can be amplified acoustically through the acoustic
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component of a hybrid implant system. Should threshold levels drop too low due to damage
caused from implantation, they are no longer of use or “aidable” for the purpose of EAS. For this
reason, hearing preservation can be deemed “non-functional” or unable to be aided acoustically.
In addressing research question three, “What proportion of hybrid cochlear implantees
maintained low frequency residual hearing following cochlear implant surgery? If so, to what
degree was low frequency hearing preserved?”, hearing preservation was achieved in all studies
to varying degrees. The ability to preserve functional hearing was overwhelmingly successful,
with between 66-100% of subjects maintaining at least partial residual hearing after
implantation. Studies also reported that between 0-33.3% of subjects experienced a total or “nonfunctional” loss of hearing. True degrees of hearing preservation were heavily dependent on the
pre-operative thresholds themselves. As a limitation to this conclusion, what each study qualified
as “preserved” varied greatly. Future research may aim to keep these degrees of preservation
more consistent and determine if these percentages can improve with improved surgical
techniques. Also of note was the four studies which reported on long-term use of EAS and its
discontinued use. Continued use had great variability with 54.5-88% of subjects still utilizing
EAS at more than one year after implantation. A common reason for discontinued use is the
further decline in hearing thresholds in the months to years following implantation, making these
subjects ineligible for acoustic stimulation. A topic of future research may look into the longterm use of EAS and the reasoning behind its dicontinued use. As EAS is a more recent
development in the realm of cochlear implants, it may now be of interest to investigate these
long term implications.
Hybrid cochlear implantation has offered a new amplification solution for a previously
excluded and underserved population. These individuals were historically treated with traditional
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hearing aids but received limited benefit from the devices. Previous restrictions prevented them
from obtaining cochlear implants as they did not meet the typical candidacy criteria. The
findings concluded in this systematic review may serve as evidentiary support for the expansion
of cochlear implantation criteria as specified by the FDA. The expansion of cochlear implant
criteria to include hybrid cochlear implant candidates should reflect the growing population of
potential users.
Table 6 outlines the candidacy criteria of an ideal EAS candidate that may benefit from
the advantages noted. As previously discussed, the FDA leaves much of the recommendation for
cochlear implantation up to the clinician. Through “off-labeling” clinicians can make a clinic
judgement of the potential benefit for a patient. However, insurance payers, particularly
Medicare, put in place candidacy restrictions that are required for approval in order to receive
coverage. The ideal candidate will meet said criteria, as specified by the FDA, for hearing
thresholds, speech scores, hearing aid benefit, and contraindications to surgery. The following
table displays the suggested criteria:
Table 6: EAS Candidacy
•
•
•
•

Ideal EAS candidate
Low frequency thresholds obtained within normal limits to a moderate sensorineural
hearing loss (approximate; exact cut-off threshold is manufacturer specific)
Mid to high frequency thresholds obtained at a severe to profound sensorineural
hearing loss
Monosyllabic speech scores of £60% in the best aided condition and £50% in the ear to
be implanted (for third party insurers- as per standard FDA candidacy criteria)
Limited benefit from appropriately fit traditional amplification after an adequate trial
period

•

No contraindications to surgery

•

No contraindications to use of an external amplification component (ie. microtia,
atresia, middle ear drainage)

(FDA, 2016); (FDA, 2018); (Med-El, 2020)
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Of importance are the advantages and disadvantages to hybrid cochlear implantation,
particularly in comparison to traditional amplification. Such advantages include improved speech
understanding, especially in noise, as demonstrated by the included studies. Potential hybrid
candidates have poor speech recognition scores such that traditional amplification cannot solve
their issues with clarity, and this difficulty is often exacerbated in noise. A secondary advantage
this review has presented is the improvement in subjective outcomes as reported by subjects. All
studies indicated subjects experienced positive improvements pre- to post- implantation
indicating a high level of satisfaction with their decision. There are potential disadvantages
associated with hybrid implantation which have also been uncovered in this review. The first of
which is the potential loss of residual hearing from implantation. The majority of studies have
indicated that while hearing preservation was overall successful, some degree of hearing was lost
in all patients to varying degrees. The trauma of surgery puts at risk the delicate structures of the
inner ear resulting in a decline in hearing. Another potential disadvantage comes from the risks
associated with any surgery. While cochlear implantation surgery is generally well-tolerated,
there are standard risks associated with any surgical procedure that should be considered.
Potential surgical complications include injury to the facial nerve, post-operative tinnitus or
vertigo, infection at the skin wound, or potential electrode migration or misplacement (Jeppesen
& Faber, 2013). For this reason, patients may choose the less invasive option. Another
disadvantage to discuss with patients is the acclimatization period and the difference in sound
quality a patient will experience post-implantation. Pre-operative counseling is essential to
prepare the patient for what to expect immediately after activation. Transparency of the benefits
and limitations of a hybrid cochlear implant can aid in this decision making. This review has
summarized the literature’s conclusions of the potential advantages and disadvantages.
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There are limitations to this review related to the inconsistency in reporting across
studies. These inconsistencies are present in different follow-up periods, different outcome
measures, and different testing conditions. For these reasons, we are limited in the conclusions
we can draw from the given data and may only report on overall trends. A second limitation is
that the electrode arrays used in the included studies are not reflective of the vast advancements
currently being used in today’s devices. As we are at the forefront of hybrid cochlear implant
usage, the technology changes rapidly and can become obsolete. Although exclusion criteria
were put in place to limit included studies to those published since 2013, the need for more
current research is evident as the devices used today do not reflect the devices used at the time of
data collection. Future recommendations and initiatives may aim at increasing awareness for
cochlear implant evaluation referrals from non-cochlear implant audiologists. The most effective
way to identify this population is to have audiologists become more aware that hybrid cochlear
implants are a potential option for these patients. Future directions of research may look at how
and when these referrals are occurring and what can be done to increase such awareness. Future
clinic recommendations should reflect the mission to refer these patients for evaluation. Without
these recommendations, we will continue to see this population perform poorly with traditional
hearing aids. Other topics of potential research include the long-term usage of hybrid cochlear
implants, as there are varying reports of use and minimal follow-up regarding reasoning of
discontinued use. Having such data may lead to a better understanding of the benefits and
limitations of said devices. Lastly, further research should be dedicated to quantifying the benefit
of acoustic stimulation in hybrid cochlear implants. This may allow for further conclusions of the
potential advantages of acoustic hearing in regards to current speech coding strategies. The
conclusions and data extracted in this review should serve to support this future research.
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Conclusions
In this systematic review, the existing literature on the speech outcomes, subjective
outcomes, and hearing preservation of hybrid cochlear implant users was extracted and reviewed.
The findings indicated an overall positive improvement in speech perception and subjective
performance from pre-operatively to post-operatively. Functional hearing preservation was well
maintained in all studies, to varying degrees, to enable to use of electric acoustic stimulation. The
concluded evidence in this review many serve as justification and evidentiary support of the
expansion of cochlear implant criteria to include this underserved population. Future research
may focus on the discontinued use of EAS, audiologist referral of this population, and the
quantifying of benefit of the acoustic component in the hybrid cochlear implant system.

55

References
Adunka, O. F., Dillon, M. T., Adunka, M. C., King, E. R., Pillsbury, H. C., & Buchman, C. A.
(2013). Hearing preservation and speech perception outcomes with electric-acoustic
stimulation after 12 months of listening experience: Hearing Preservation and Speech
Perception Outcomes with EAS. The Laryngoscope, n/a-n/a.
https://doi.org/10.1002/lary.23741
Bierer, J. A., Spindler, E., Bierer, S. M., & Wright, R. (2016). An Examination of Sources of
Variability Across the Consonant-Nucleus-Consonant Test in Cochlear Implant Listeners.
Trends in Hearing, 20, 233121651664655. https://doi.org/10.1177/2331216516646556
Carvalho, G. M. de, Guimaraes, A. C., Duarte, A. S. M., Muranaka, E. B., Soki, M. N., Martins,
R. S. Z., Bianchini, W. A., Paschoal, J. R., & Castilho, A. M. (2013). Hearing
Preservation after Cochlear Implantation: UNICAMP Outcomes. International Journal of
Otolaryngology, 2013, 1–8. https://doi.org/10.1155/2013/107186
FDA. (2016). Premarket Approval: NUCLEUS HYBRID L24 COCHLEAR IMPLANT SYSTEM
(PMA no:P130016). Retrieved from
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm?id=P130016
FDA. (2018). "Off-Label" and Investigational Use of Marketed Drugs, Biologics, and Medical
Devices: Guidance for Institutional Review Boards and Clinical Investigators. Retrieved
from https://www.fda.gov/regulatory-information/search-fda-guidance-documents/labeland-investigational-use-marketed-drugs-biologics-and-medical-devices.
Gantz, B. J., Dunn, C., Oleson, J., Hansen, M., Parkinson, A., & Turner, C. (2016). Multicenter

56

clinical trial of the Nucleus Hybrid S8 cochlear implant: Final outcomes: S8 Hybrid
Cochlear Implants. The Laryngoscope, 126(4), 962–973.
https://doi.org/10.1002/lary.25572
Gatehouse, S., & Noble, W. (2004). The Speech, Spatial and Qualities of Hearing Scale (SSQ).
International Journal of Audiology, 43(2), 85–99.
https://doi.org/10.1080/14992020400050014
Gifford, R. H. (2013). Cochlear implant patient assessment: evaluation of candidacy,
performance, and outcomes. Plural Pub.
Gifford, R. H., Dorman, M. F., Skarzynski, H., Lorens, A., Polak, M., Driscoll, C. L. W.,
Roland, P., & Buchman, C. A. (2013). Cochlear Implantation With Hearing Preservation
Yields Significant Benefit for Speech Recognition in Complex Listening Environments:
Ear and Hearing, 34(4), 413–425. https://doi.org/10.1097/AUD.0b013e31827e8163
Gifford, R. H., Grantham, D. W., Sheffield, S. W., Davis, T. J., Dwyer, R., & Dorman, M. F.
(2014). Localization and interaural time difference (ITD) thresholds for cochlear implant
recipients with preserved acoustic hearing in the implanted ear. Hearing Research, 312,
28–37. https://doi.org/10.1016/j.heares.2014.02.007
Group Product Manager, Surgical & Implants, Cochlear Limited, New South Wales, Australia,
& Risi, F. (2019). Considerations and Rationale for Cochlear Implant Electrode Design Past, Present and Future. The Journal of International Advanced Otology, 14(3), 382–
391. https://doi.org/10.5152/iao.2018.6372
Härkönen, K., Kivekäs, I., Kotti, V., Sivonen, V., & Vasama, J.-P. (2017). Hybrid cochlear
implantation: quality of life, quality of hearing, and working performance compared to
patients with conventional unilateral or bilateral cochlear implantation. European

57

Archives of Oto-Rhino-Laryngology, 274(10), 3599–3604.
https://doi.org/10.1007/s00405-017-4690-9
Jeppesen, J., & Faber, C. E. (2013). Surgical complications following cochlear implantation in
adults based on a proposed reporting consensus. Acta Oto-Laryngologica, 133(10), 1012–
1021. https://doi.org/10.3109/00016489.2013.797604
Kong, Y.-Y., Stickney, G. S., & Zeng, F.-G. (2005). Speech and melody recognition in
binaurally combined acoustic and electric hearing. The Journal of the Acoustical Society
of America, 117(3), 1351–1361. https://doi.org/10.1121/1.1857526
Lenarz, T., James, C., Cuda, D., Fitzgerald O’Connor, A., Frachet, B., Frijns, J. H. M., Klenzner,
T., Laszig, R., Manrique, M., Marx, M., Merkus, P., Mylanus, E. A. M., Offeciers, E.,
Pesch, J., Ramos-Macias, A., Robier, A., Sterkers, O., & Uziel, A. (2013). European
multi-centre study of the Nucleus Hybrid L24 cochlear implant. International Journal of
Audiology, 52(12), 838–848. https://doi.org/10.3109/14992027.2013.802032
Looi, V., Gfeller, K., & Driscoll, V. (2012). Music Appreciation and Training for Cochlear
Implant Recipients: A Review. Seminars in Hearing, 33(4), 307–334.
https://doi.org/10.1055/s-0032-1329222
Med-El. (2020). Candidacy for EAS. Retrieved from https://www.medel.com/eas-candidacy
Moher D., Liberati A., Tetzlaff J., Altman D.G., The PRISMA Group (2009). Preferred
Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement.
PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed100009
Roland, J. T., Gantz, B. J., Waltzman, S. B., & Parkinson, A. J. (2018). Long-term outcomes of

58

cochlear implantation in patients with high-frequency hearing loss: Long-Term ElectricAcoustic Hearing Outcomes. The Laryngoscope, 128(8), 1939–1945.
https://doi.org/10.1002/lary.27073
Roland, J. T., Gantz, B. J., Waltzman, S. B., Parkinson, A. J., & The Multicenter Clinical Trial
Group. (2016). United States multicenter clinical trial of the cochlear nucleus hybrid
implant system: Nucleus Hybrid Implant System Clinical Trial. The Laryngoscope,
126(1), 175–181. https://doi.org/10.1002/lary.25451
Santa Maria, P. L., Domville-Lewis, C., Sucher, C. M., Chester-Browne, R., & Atlas, M. D.
(2013). Hearing Preservation Surgery for Cochlear Implantation—Hearing and Quality of
Life After 2 Years: Otology & Neurotology, 34(3), 526–531.
https://doi.org/10.1097/MAO.0b013e318281e0c9
Skarzynski, H., Lorens, A., Matusiak, M., Porowski, M., Skarzynski, P. H., & James, C. J.
(2014). Cochlear Implantation With the Nucleus Slim Straight Electrode in Subjects With
Residual Low-Frequency Hearing: Ear and Hearing, 35(2), e33–e43.
https://doi.org/10.1097/01.aud.0000444781.15858.f1
Speech Processing in the Auditory System (Vol. 18). (2004). Springer-Verlag.
https://doi.org/10.1007/b97399
Usami, S.-I., Moteki, H., Tsukada, K., Miyagawa, M., Nishio, S.-Y., Takumi, Y., Iwasaki, S.,
Kumakawa, K., Naito, Y., Takahashi, H., Kanda, Y., & Tono, T. (2014). Hearing
preservation and clinical outcome of 32 consecutive electric acoustic stimulation (EAS)
surgeries. Acta Oto-Laryngologica, 134(7), 717–727.
https://doi.org/10.3109/00016489.2014.894254
Woodson, E. A., Reiss, L. A. J., Turner, C. W., Gfeller, K., & Gantz, B. J. (2009). The Hybrid

59

Cochlear Implant: A Review. In P. Van de Heyning & A. Kleine Punte (Eds.), Advances
in Oto-Rhino-Laryngology (Vol. 67, pp. 125–134). KARGER.
https://doi.org/10.1159/000262604

60

